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Abstract 
Cytochrome b is the only subunit of complex III (CIII, ubiquinol:cytochrome c 
oxidoreductase) encoded by the mitochondrial DNA (mtDNA). Constituting the central 
core of CIII, this protein is essential for both assembly and catalytic activity of the 
complex. CIII is a dimer (CIII2) in its native form and can closely associate in varying 
proportions with complex I (CI) and complex IV (CIV) to form supramolecular structures, 
referred to as supercomplexes (SCs). Defects in CIII are relatively rare and mostly 
associated with mutations in the MTCYB gene encoding cytochrome b. MTCYB mutations 
can affect CIII only or both CI and CIII, likely as a consequence of the critical role of this 
latter complex on the stability of CI within the SCs.  
In this study, we have investigated the effects of two pathogenic mutations 
affecting MTCYB: the p.278Y>C missense mutation, causing the substitution of the highly 
conserved Tyr278 close to the QO site, and the ΔI300-P305 microdeletion, producing the 
loss of six aminoacids in the sixth transmembrane helix, but leaving the remaining of the 
MTCYB coding region in frame. The biochemical analysis has been carried out taking 
advantage of a cell model specifically developed to investigate the mtDNA mutations, the 
cybrids, derived from fusion of enucleated patient’s fibroblasts with 143B-osteosarcoma 
cells devoid of their own mtDNA. We were able to generate cybrids bearing each of the 
two pathogenic mutations in homoplasmic and heteroplasmic conditions. We have 
demonstrated that both homoplasmic MTCYB mutations severely impaired the activity of 
CIII: the missense mutation produced an oxidative damage of CIII due to increased 
superoxide production, whereas in cells bearing the ΔI300-P305 microdeletion, CIII was 
not detected, with consequent derangement also of CI. The detailed analysis of SCs 
organization revealed in both cases a strong perturbation of the CIII2+IV SC, together 
with an attempt to preserve the respirasome stability. Indeed, in p.278Y>C cells, the 
CI+III2+IV SC was slightly increased, whereas in ΔI300-P305 a minimal amount of the 
CI+III2 SC was maintained despite the almost complete disassembly of CI and CIII. These 
results favor the hypothesis that SCs not only preserve the structure and stability of 
respiratory complexes, but become crucial for attenuating the mitochondrial dysfunction 
due to the occurrence of pathogenic mutations affecting the enzymes.  
Abstract 
2 
 
Moreover, in cells bearing the ΔI300-P305 deletion, analysis of SCs also evidenced 
the presence of a high molecular weight SC, containing CI, CIII and CIV, mostly 
associated to heteroplasmic clones. This unusual high molecular weight SC, which was not 
detected in controls, might derive from the presence of both wild-type and mutant 
cytochrome b in the same cells, a situation similar to that occurring in many patient’s 
tissues.  
 Finally, in cells with the homoplasmic ΔI300-P305 deletion only, we described a 
marked increase in complex II (CII) redox activity, which was associated with significant 
hydrogen peroxide production. In addition, analysis by western blotting revealed that the 
band corresponding to SDHA-CII subunit only was positive to anti P-tyrosine antibody, 
suggesting the involvement of a tyrosine kinase-dependent mechanism in CII activation. 
Interestingly, prolonged treatment with the antioxidant N-acetylcysteine dampened both 
hydrogen peroxide production and CII activity stimulation, and caused the disappearance 
of the P-tyrosine positive band of SDHA subunit. It is noteworthy that CII activity was not 
detected in cells with the p.278Y>C missense mutation, despite the complete inhibition of 
CIII. Enhanced CII activity is a rather general phenomenon in cell adaptation to 
respiratory chain dysfunction, being detected also in CIII-deficient cells provided that 
hydrogen peroxide production is increased. 
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Introduction 
1.1 Mitochondria 
Mitochondria are cytoplasmatic organelles present within eukaryotic cells. The 
number of mitochondria differs depending on the tissues energy request, such as skeletal 
muscle or kidney, which are tissues with a high energy requirement, have a larger number 
of mitochondria. They are the descendants of endosymbiotic α-proteobacteria adapted to 
an increasingly oxygen-rich atmosphere that invaded progenitors of contemporary 
eukaryotes approximately 1.5–2 billion years ago [Margulis, 1970]. The organelles still 
maintain some characteristics of their ancestor bacteria, as, in particular, their own genome, 
the presence of a double membrane, the ability to synthesize adenosine triphosphate (ATP) 
and an independent protein synthesis apparatus. 
Mitochondria are often referred as the “powerhouses” of the cells because of their 
main role in the cellular energy production, in the form of ATP, via the oxidative 
phosphorylation (OXPHOS) system. However, in addition to ATP generation, 
mitochondria are involved in other important pathways, such as the Krebs cycle, fatty acid 
oxidation, and metabolism of amino acid and hormones [Shadel and Horvath, 2015]. 
Moreover, they play a critical role in generation of cellular signals, such as reactive oxygen 
species (ROS) [Dan Dunn et al., 2015], control of cytosolic calcium (Ca2+) concentration 
[Finkel et al., 2015], modulation of oxidation–reduction (redox) status through the assembly 
of iron-sulfur clusters [Stehling et al., 2014], apoptosis [Lopez and Tait, 2015] and innate 
immunity [Weinberg et al., 2015]. 
Mitochondria were described for the first time in 1890 by Richard Altmann. He 
called them “bioblasts” [βιός (bios), life; βλαστός (blastos), germ] to indicate that these 
cytoplasmic ubiquitous structures existing in the cells were “elementary organisms” 
carrying out vital functions and resembling bacteria [Altmann, 1980]. The term 
mitochondrion [from the Greek µίτος (mitos), thread and χονδρίον (kondrion), granule] 
was coined by Carl Benda in 1898, referring to the structure appearance of the organelle 
[Benda, 1898]. 
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1.1.1 Mitochondrial structure 
Mitochondria are about 0.5–1 μm in diameter and up to 7 μm long organelles. 
They are separated from the cytoplasm by the outer and the inner membrane, which are 
different in appearance and in physicochemical properties. The two membranes are 
characterized by different phospholipid compositions and protein-to-lipids ratio, 50:50 for 
the outer membrane and 80:20 for the inner membrane. The outer membrane is porous 
and freely permeable to ions and small, uncharged molecules through the pore-forming 
membrane proteins porins. The larger molecules, such as proteins, are imported in by 
translocases. On the other hand, the inner membrane cannot be freely traversed, thus ions 
and larger molecules can cross this membrane through specific membrane transport 
proteins or carriers, which are highly selective. In particular, the proton selectivity of the 
inner membrane causes the formation of a proton electrochemical potential (H+), where 
the electrical component (m), negative inside, is about 180 mV. The presence of the 
inner and outer membranes creates four compartments within the mitochondrion. The first 
one is the mitochondrial matrix, enclosed by the inner membrane. The matrix has a high 
pH (~7.9-8), due to the H+, and is the site of organellar DNA replication, transcription, 
protein biosynthesis and numerous enzymatic reactions. Between the matrix and the intra-
membrane space, the inner membrane is located. It contains several carrier proteins 
shuttling ions, ATP, ADP and small metabolites between the cytoplasm and the matrix. 
Actually, the inner membrane can be divided into two sub-compartments: the inner 
boundary membrane, facing the outer membrane, and the cristae membrane. Cristae are 
formed by inner membrane invaginations into the matrix, greatly increasing the surface of 
the inner membrane compared to the outer membrane. Cristae are continuous with the 
inner boundary membrane through the crista junctions, whose components only start to be 
known, which are also connected with the outer membrane [Harner et al., 2011]. Cristae 
contain most of the complexes of the electron transport chain and the ATP synthase, thus 
becoming the main site of energy production (Figure 1.1) [Kühlbrandt, 2015].  
Initially, mitochondria were believed to be single static entities. Today, it is well 
known mitochondria form a highly dynamic network which continuously moves and fuses, 
undergoing membrane remodeling through cycles of fusion (two mitochondria joining to 
form a single mitochondrion) and fission (a single mitochondrion dividing into two 
fragments) [Lackner, 2014]. The balance between fusion and fission controls the 
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mitochondrial structure, shifting the numerous separate mitochondria in single or 
interconnected membranous structures [Mishra and Chan, 2014]. 
 
Figure 1.1 A schematic picture of a mitochondrion. The red lines indicate the mitochondrial membranes and 
compartments. The mtDNA and the OXPHOS complexes in the inner membrane are also indicated. 
 
1.1.2 Mitochondrial genome 
As result of bacteria endosymbiosis, mitochondria have their own genome. In 
humans mitochondrial DNA (mtDNA) is a circular double-stranded molecule long 
approximately 16.569 base pairs. The two strands are referred to as the heavy strand (H-
strand, rich in guanine) and the light strand (L-strand, rich in cytosine). The mtDNA is 
highly compact, indeed, there are no introns or intergenic noncoding sequences, with the 
exception of the 1.1 kb displacement loop (D-loop), forming a triple-stranded structure, 
and a 30 nucleotides sequence containing the origin of replication for the L-strand (OriL). 
D-loop contains one transcription promoter for each strand (light strand promoter, LSP; 
heavy strand promoter, HSP) and the origin of replication for the H-strand (OriH). 
Furthermore, mitochondrial genome has some of the coding regions overlapping each 
other (Figure 1.2) [Anderson et al., 1981; Uhler and Falkenberg, 2015]. MtDNA is 
organized into DNA-protein complexes called nucleoids, which are believed to be 
associated with the inner mitochondria membrane, exchanged between mitochondria. Each 
nucleoid was shown to frequently contain only a single copy of mtDNA, packed with 
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several molecules (one thousand) of the transcription activator TFAM, but also other 
proteins involved in mitochondrial replication, maintenance, repair and recombination may 
be of importance [Kukat et al., 2015]. During evolution, mitochondria have gradually 
transferred most of genetic material to the nucleus, thus mtDNA contains only 37 genes, 
encoding 13 subunits of the OXPHOS system, 2 ribosomal RNAs (rRNAs) and 22 transfer 
RNAs (tRNAs), required for translation of the mitochondria-encoded proteins. All the 
other proteins, including those required for mtDNA replication and transcription, are 
imported from the cytosol [Uhler and Falkenberg, 2015]. The complete sequence of the 
human mtDNA was obtained in 1981 [Anderson et al., 1981] with further investigation in 
1999 [Andrews et al., 1999]. 
 
 
 
Figure 1.2 Schematic map of the human mitochondrial genome. ND1-ND6 and ND4L, which overlap with 
ND4, encode CI subunits; MTCYB encodes the CIII subunit; COI-COIII encode CIV subunits; ATP6 and 
ATP8, which are overlapped each other, encode CV subunits. The D-loop, the genes encoding for 12S and 
16S ribosomal RNAs, the tRNAs (as single letter amino acid code abbreviation, red circles), the origin of 
replication and the transcription promoters are indicated [modified from Yusoff et al., 2015]. 
 
1.1.2.1 Replication, transcription and translation 
The replication of mtDNA is independent of the cell cycle and the nuclear 
genome. The enzyme involved in the mitochondrial replication is the mitochondrial 
polymerase γ (POLG) with the mutuality of the helicase TWINKLE, of TFAM and of a 
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ligase [Ferreira et al., 2015]. The replication mechanism is still debated, three different 
model have been proposed: (i) in the asynchronous mechanism, the replication starts at the 
origin of the H-strand, proceeds around two-thirds of the mitochondrial genome, until the 
L-strand origin is exposed, initiating the replication in the opposite direction [Clayton, 
1982]; (ii) in the strand-coupled model, the replication of H-strand and L-strand starts 
simultaneously [Holt et al., 2000]; (iii) in the RITOLS model (RNA Incorporated Through 
Out the Lagging Strand), the replication proceeds unidirectionally from the D-loop region, 
with RNA replication intermediates which are subsequently maturated into DNA 
[McKinney and Oliveira, 2013; Yasukawa et al., 2006]. 
The transcription of mitochondrial genes starts from promoters on both H-strand 
(HSP1 and HSP2) and L-strand (LSP). It requires the mitochondrial RNA polymerase 
(POLRMT), the TFAM and the mitochondrial transcription factor B1 or B2. The 
termination of mature transcripts is carried out by mitochondrial termination factor 1 
(MTERF1). The mitochondrial transcription generates polycistronic transcripts, which 
produce, after processing, individual mRNA, rRNA and tRNA molecules [Ferreira et al., 
2015].  
The translation of mitochondrial proteins is still an unclear process. The 
mitochondrial protein synthesis machinery is independent from the cytosolic ribosome and 
takes place within the matrix. The mito-ribosomes (the mitochondrial ribosome) are 
assembled by the two mitochondrial rRNAs and nuclear encoded proteins. Translation 
requires the two mitochondrial initiation factors, mtIF1 and mtIF3, this later causing the 
dissociation of the mitoribosomes and consequently the assembly of the initiation complex. 
Then, mRNA is bound the small subunit, aligning the start codon to the peptidyl site of the 
mito-ribosome. Peptide elongation is controlled by a number of nuclear-encoded genes, 
including mitochondrial elongation factor Tu (mtEFTu), which binds the tRNA to the 
mito-ribosome and mitochondrial elongation factor G1 (mtEFG1), required to move the 
newly added amino acid along one position and allowing amino acid inclusion. Translation 
termination is carried out solely by mitochondrial release factor 1a (mtRF1a), which 
recognizes the stop codons (UAA and UAG) and triggers hydrolysis of the bond between 
the terminal tRNA and the nascent peptide [Chinnery and Hudson, 2013]. 
1.1.3 Mitochondrial genetics 
Mitochondrial genetics is deeply different from the Mendelian genetics at least in 
four main aspects. First, mtDNA is exclusively inherited through the maternal lineage. 
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After fertilization of the oocyte, sperm mtDNA is ubiquitinated and consequently 
removed. Therefore, the mtDNA content of the zygote is determined exclusively by the 
previously unfertilized egg. The lack of paternal inheritance is still debated, three 
mechanism are suggested: (i) a dilution effect (sperm contain only 100 copies of mtDNA, 
compared with 100 000 in the unfertilized egg), (ii) selective ubiquitination of paternal 
mtDNA or (iii) the “mtDNA bottleneck” excludes the “minor” paternal alleles [Sutovsky, 
2003]. Second, the genome of the organelle has a genetic code which is different from the 
nuclear code; for instance, unlike the nuclear genetic code, “UGA” is not a stop codon but 
it encodes tryptophan or “AUA” encodes methionine and not isoleucine [Tuppen et al., 
2010]. Third, mitochondrial genome is polyploid with multiple copies of mtDNA per 
mitochondrion (2-10 copies) and 1000–10.000 copies within cells. This latter feature gives 
rise to the concept of heteroplasmy and homoplasmy of mtDNA. Heteroplasmy is referred 
to the situation where different mitochondrial genotypes coexist within the same cell, tissue 
or organism, whereas homoplasmy is referred to the situation where all copies of mtDNA 
are identical [Keogh and Chinnery, 2015]. Finally, mtDNA follows mitotic segregation, 
indeed during mitosis, mitochondria are randomly segregated, and in heteroplasmic cells, 
the proportion of mutant mtDNA in the daughter cells can thus shift, causing 
accumulation or loss of one of the mtDNA copies [Park and Larsson, 2011]. 
 
1.2 The OXPHOS  
Mitochondria are referred as “the powerhouses” of the cell because of their role 
in energy production, in the form of ATP, through the metabolic process known as 
OXPHOS. The ATP production is fueled by metabolites derived from glycolysis, β-
oxidation and Krebs cycle. Briefly, pyruvate, derived from glucose via glycolysis, is 
transported into mitochondria and metabolized by the pyruvate dehydrogenase complex 
resulting in acetyl-CoA. Fatty acids are activated to acyl-CoAs which are transferred into 
mitochondria and oxidized by β-oxidation to acetyl-CoA. Acetyl-CoA then enters the 
Krebs cycle where it is oxidized generating CO2, succinate and reduced coenzymes such as 
NADH and FADH2. Reducing equivalents are produced also during glycolysis and β-
oxidation [Lenaz and Genova, 2010; Szalárdy et al., 2015; Wallace and Fan, 2010]. 
NADH and FADH2 act as electron donors to the complexes of the respiratory 
chain embedded within the inner mitochondrial membrane. NADH provides electrons to 
complex I (CI, NADH:ubiquinone oxidoreductase), FADH2 to complex II (CII, 
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succinate:ubiquinone oxidoreductase). The electrons are then transported to complex III 
(CIII, ubiquinol:cytochrome c oxidoreductase) via the lipophilic mobile redox-active 
molecule coenzyme Q (ubiquinone; CoQ; quinone) and flow through cytochrome c to 
complex IV (CIV, cytochrome c oxidase) where O2, the final electrons acceptor, is reduced 
to H2O. During the electron transport, CI, CIII and CIV pump out protons from the 
matrix across the inner membrane, generating the electrochemical gradient (ΔH+), 
consisting of a proton gradient (ΔpH, alkaline in the matrix side) and an electrical potential 
(ΔΨm: ~ -180 mV; negative in the matrix) across the membrane [Mitchell, 1961]. The three 
complexes catalyze the translocation of 10 protons from the matrix to the inter-membrane 
space for each NADH molecule oxidized. The electrochemical gradient (also called proton 
motive force) drives back the protons into matrix via ATP synthase (complex V, CV) 
inducing conformational changes in the active site of the enzyme and consequently 
promoting the phosphorylation of ADP to ATP (Figure 1.3) [Nath and Villadsen, 2015; 
Sazanov, 2015; Szalárdy et al., 2015; Wallace and Fan, 2010].  
 
 
Figure 1.3 The OXPHOS system consisting in CI, CII, CIII and CIV and the ATP synthase [modified from 
Sazanov, 2015]. 
 
In addition to ATP synthesis, ΔH+ is used for other important mitochondrial 
functions such as the import of nucleus-encoded proteins in the matrix, the uptake of 
inorganic phosphate, the ADP/ATP exchange, the maintenance of ion homeostasis, in 
particular of Ca2+ ions [Bernardi, 1999; Bernardi et al., 2015; Rizzuto et al., 2012]. 
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1.2.1 The ATP synthase 
Mitochondrial ATP synthase or CV is a large protein complex which works as a 
molecular motor to generate and hydrolyze ATP in cells. ATP synthase generates ATP 
from ADP and Pi using the driving force of the ΔH+ built up across the inner membrane 
by the respiratory CI, CIII and CIV. On the other hand, ATP synthase can hydrolyze ATP 
to pump protons back to the inter-membrane space to maintain membrane potential at the 
expenses of glycolytic ATP [Bernardi et al., 2015; Futai et al., 2012; Long et al., 2015; 
Walker, 2013]. 
As illustrated in Figure 1.4, ATP synthase consists of two distinct subcomplexes 
with complementary functions: the F0 complex containing the rotatory trans-membrane 
subunits that transport protons from the inter-membrane space to the matrix, and the F1 
complex, protruding into the matrix, which catalyzes nucleotide binding and ATP 
synthesis. F0 and F1 are connected through two stalk-like subunits: a central rotor shaft and 
a peripheral stator [Abrahams et al., 1994; Chen et al., 2004; van Raaij et al., 1996]. In the 
mammalian enzyme, F1 is composed of three copies each of nucleotide-binding subunits α 
and β, and one each of subunits γ, δ and ε. Subunit γ, together with δ and ε subunits, forms 
the central stalk which connect F1 with F0. F0 consists of a c-ring, constituted by 10-14 
copies of the subunit c, and one copy each of subunits a, b, d, h (F6) and the O subunit or 
oligomycin sensitivity conferring protein (OSCP). A number of additional subunits (e, f, g, 
i/j, k and A6L) are associated with F0, although their precise location within the complex 
remains unknown. All subunits of ATP synthase are encoded by nuclear genome, except 
for ATP6 and ATP8 which are encoded by mtDNA [Chen et al., 2006; Gibbons et al., 2000; 
Karrasch and Walker, 1999; Rubinstein et al., 2003]. Protons accumulated in the inter-
membrane space are driven through a semi-channel in F0, which causes rotation of the c-
ring along with the attached central stalk. Subsequently, rotation of subunit γ, within the F1-
α3β3 hexamer provides energy for ATP synthesis at the catalytic sites (located in each of the 
three β subunits, at the interface with an adjacent α subunit) [Bernardi et al., 2015; Long et 
al., 2015; Noji et al., 1997; Walker, 2013]. 
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Figure 1.4 Schematic representation of the ATP synthase. 
 
The ATP synthase is present in the inner membrane as a dimer or a monomer. 
The F0 subunits e, g, k and i were identified to be essential for the dimerization [Arnold et 
al., 1998; Davies et al., 2014; Dudkina et al., 2005b, 2006; Giorgio et al., 2013]. The presence 
of ATP synthase dimer was shown to be essential for the cristae structure formation and 
maintenance and consequently for the normal mitochondrial energetic function [Chaban et 
al., 2014; Dudkina et al., 2005b; Seelert and Dencher, 2011; Velours et al., 2009]. 
 
1.3 The respiratory chain 
As introduced in 1.2 paragraph and summarized in Figure 1.3, the respiratory 
chain is constituted by four large protein complexes embedded within the inner membrane 
transferring electrons from NADH or FADH2 to oxygen. CI, CIII and CIV, but not CII, 
are able to promote the efflux of protons into the inter-membrane space generating the 
H+ [Lenaz and Genova, 2010; Szalárdy et al., 2015; Wallace and Fan, 2010]. These 
complexes contain multiple redox cofactors to facilitate intra-complex electron transfer 
[prosthetic group such as flavin mononucleotide (FMN) and Fe-S clusters] and are 
connected each other by two mobile redox-active molecules: coenzyme Q, embedded in 
the inner membrane, and cytochrome c, outside the inner membrane [Lenaz and Genova, 
2010]. By using a combination of spectrophotometry-based enzymatic assays, 2D/SDS-
PAGE complex separation and Coomassie blue-staining, a ratio of one CI to 1.3 CII to 
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three CIII to 6.7 CIV in beef heart mitochondria was determined [Schägger and Pfeiffer, 
2001]. 
Auxiliary enzymes of the respiratory chain are the mitochondrial glycerol-3-
phosphate dehydrogenase (mtGPDH), the electron-transfer ﬂavoprotein (ETF):ubiquinone 
oxidoreductase, the choline dehydrogenase, the dihydroorotate dehydrogenase and the 
alternative NADH dehydrogenases which transfer electrons to CoQ. Another auxiliary 
enzyme which feed electrons to CoQ is the malate:quinone oxidoreductase which is found 
only in some eukaryotes. In addition to CIII, all eukaryotic mitochondria possess the sulfite 
oxidase which feeds electrons to cytochrome c. Moreover, within mitochondria of plants, 
some yeasts and fungi an alternative quinol oxidases is found, catalyzing the aerobic 
oxidation of ubiquinol in addition to the cytochrome pathway. Unlike the above indicated 
respiratory complexes, the auxiliary enzymes are not involved in generation of the 
protonmotive force [Lenaz and Genova, 2010]. 
 
1.3.1 Complex I 
Mitochondrial CI (NADH:ubiquinone oxidoreductase; EC 1.6.5.3) is the largest 
complex of the respiratory chain. In mammals, the enzyme comprises 44 subunits, seven of 
which are encoded by mitochondrial genome [Carroll et al., 2006]. Our knowledge of the 
structure and function of this complex derives from the bacterial enzymes, constituted of 
14 conserved subunits necessary and sufficient for the catalytic activity. The 14 subunits are 
defined as core subunits and classified into three distinct modules: the N-, Q- and P-
module, that together form the typical L-shaped structure.  
The first intact CI structure was recently solved in the T. thermophilus enzyme to 
3.3 Å resolution completing the model of the core subunits [Baradaran et al., 2013]. Figure 
1.5A shows that the NADH-dehydrogenase N-module, which provides electron input into 
the chain of Fe–S clusters, and the connecting Q-module, which conducts electrons to the 
quinone-binding site, compose the peripheral arm of CI. It contains seven conserved core 
subunits: Nqo1, Nqo2, Nqo3, Nqo4, Nqo5, Nqo6, Nqo9 and cofactors including 8-9 Fe-S 
clusters and the FMN molecule. Seven of the Fe-S clusters form a 95 Å-long redox chain 
connecting FMN to the quinone-binding site at the interface with the membrane domain 
(Figure1.5B). Nqo1 coordinates the FMN in a solvent-exposed cavity which contains also 
the NADH binding site. The peripheral arm of T. thermophilus CI contains two additional 
subunits Nqo15 and Nqo16, as possible chaperon [Baradaran et al., 2013; Efremov and 
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Sazanov, 2012; Letts and Sazanov, 2015; Sazanov, 2015]. The proton pumping P-module is 
part of the membrane-arm of CI containing the core subunits Nqo7, Nqo10, Nqo11, 
Nqo14, Nqo13 and Nqo12. The membrane-arm also contains the highly conserved core 
subunit Nqo8 which is not included in the P-module. Nqo8 plays a key role in the Q 
binding site, the proton translocation pathway and the junction the peripheral- and 
membrane-arm. All of membrane-arm subunits contain 14 trans-membrane helices each. 
Nqo12 contains a C-terminal extension comprising two trans-membrane helices connected 
by a 110 Å-long α-helix that runs along the cytoplasmic membrane surface, linking the 
Nqo12, Nqo13 and Nqo14 subunits. The 14 common trans-membrane helices of Nqo12, 
Nqo13 and Nqo14 are divided in the 10-trans-membrane helices core (containing the 
helices from 4 to 13) and the less conserved 1-3-14 trans-membrane helices. Nqo7, Nqo10, 
Nqo11 and Nqo8 are connected to Nqo12, Nqo13 and Nqo14 through a 11-trans-
membrane helices bundle. On the periplasmic side of the membrane arm a series of 
connected β-hairpins and helices form the element βH. The total molecular weight of the 
bacterial CI is ~550 kDa (Figure 1.5A) [Baradaran et al., 2013; Efremov et al., 2010; 
Efremov and Sazanov, 2011; Letts and Sazanov, 2015; Sazanov, 2015]. 
The complete structure of mitochondrial CI is not available yet. The cryo-EM 
map of bovine CI at 5Å resolution [Vinothkumar et al., 2014] and the electron density map 
of CI from the yeast Yarrowia lipolytica obtained at ~3.8 Å resolution [Zickermann et al., 
2015] were recently published. These studies showed that the core is very similar to the 
bacterial enzyme, except for small variation in C- and N-termini length of subunits, and the 
presence of ~30 supernumerary subunits forming a shell around the 14 conserved core 
subunits, predominantly in the membrane- and lower peripheral-arm (Figure 1.6). These 
accessory subunits increases the molecular weight of enzyme to ~1 MDa. Currently, only 
14 accessory subunits are identified and with an assigned structure position [Vinothkumar 
et al., 2014]. The function of these supernumerary subunits is still unclear, it has been 
suggested they can assist the assembly, regulation and stability of the complex [Letts and 
Sazanov, 2015; Vinothkumar et al., 2014]. 
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Figure 1.5 (A) Structural model of T. thermophilus CI. The subunits are represented with different colors each 
and labeled with text in the same colors. The N-, Q- and P-module are shown [modified from Baradaran et al., 
2013]; (B) Electron transfer pathway from FMN to quinone through Fe-S clusters [from Sazanov, 2015]. 
 
 
Treatment of purified bovine CI with a mild detergent such as 
lauryldimethylamine oxide (LDAO) revealed that the enzyme dissociates in four sub-
complexes named Iα, Iβ, Iγ and Iλ. Subcomplex Iλ corresponds to peripheral arm, 
containing 14 subunits (7 core subunits and 7 supernumerary subunits), the redox cofactors 
and the NADH binding site. Iα subcomplex is composed by Iλ subcomplex plus 9 
additional subunits, such as ND1. The Iβ subcomplex is composed of the core subunits 
ND4 and ND5 and an additional 12 supernumerary subunits. Finally, subcomplex Iγ is 
formed by ND2 and three supernumerary subunits. Iβ and Iγ subcomplexes provide the 
membrane arm (Figure 1.7) [Letts and Sazanov, 2015; Vinothkumar et al., 2014; 
Zickermann et al., 2015]. 
The entry-point of the subunits encoded by mitochondrial genome involved in 
the assembly of mammalian CI has been recently identified [Perales-Clemente et al., 2010]. 
ND1 and ND2 define two different sub-complexes which progress separately. ND1 joins 
peripheral-arm subunits, forming an ∼400-kDa intermediate that is anchored to the inner 
mitochondrial membrane. ND2 is placed in ∼460-kDa membrane sub-complex which 
joins the ND1 subassembly building the complete CI. Thus, ND1 is the first mtDNA-
encoded subunit which enters in the ~ 400 kDa-subcomplex, the second step is 
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represented by ND2, ND3 and ND4L in the ~ 460 kDa-subcomplex. Finally, ND4, ND6 
and ND5 are incorporated into complete CI as third, fourth and fifth entry points, 
respectively [Perales-Clemente et al., 2010]. 
 
 
Figure 1.7 5 Å resolution structure of CI from Bos taurus heart mitochondria determined by single-particle 
electron cryo-microscopy. Iα, Iβ, Iγ and Iλ domains are highlighted [from Letts and Sazanov, 2015]. 
 
 
Other studies carried out in hamster chinese and human cells helped to clarify 
how the mammalian CI is assembled. As illustrated in Figure 1.8, the core subunits 
NDUFS2 and NDUFS3 form a small hydrophilic assembly complex. Then, NDUFS7, 
NDUFS8 and later NDUFA9 are incorporated forming the early peripheral complex. This 
complex forms a ~400 kDa assembly intermediate, together with a small membrane 
complex containing ND1. This ~400 kDa complex incorporates with a ~460 kDa 
membrane complex containing ND3, ND6, ND2, ND4L and NDUFB6 to form a ~650 
kDa complex. Another membrane complex containing ND4, ND5 and probably 
NDUFC2, is associated to ~650 kDa complex, forming an ~ 830 kDa complex. 
Meanwhile, the N-module is assembled by some nDNA-encoded subunits directly or 
indirectly involved in binding and oxidizing NADH. With the addition of the N-module 
and remaining subunits (such as the inter-membrane space subunits NDUFA8 and 
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NDUFS5), mature CI is assembled [Letts and Sazanov, 2015; Mckenzie and Ryan, 2010; 
Mimaki et al., 2012]. 
The catalytic mechanism of CI can be simply described as the NADH oxidation 
by FMN with the consequent transfer of two electrons along the Fe-S clusters to the 
ubiquinone binding site where quinone is reduced to quinol [Hirst, 2013]. The pathway 
starts with NADH binding to its site in the NDUFV1 subunit on the top part of the 
peripheral arm. The nicotinamide ring of NADH is juxtaposed over FMN isoalloxazine 
system, allowing the electron transfer and reduction of FMN [Berrisford and Sazanov, 
2009]. Seven of the Fe-S clusters form a chain to carry electrons from the FMN to quinone 
bound into its site (Figure 1.5B) [Baradaran et al., 2013]. The FMN reduction and the 
quinone reduction in the chain involve the transfer of two electrons, whereas Fe–S clusters 
transfer one electron at a time [Sazanov, 2015]. Electron transfer along the seven clusters 
chain is generally considered fast [Page et al., 1999], indeed each catalytic cycle would take 
~5 milliseconds [Vinogradov, 1998]. The electron transfer pathway ends in the quinone-
binding site formed by subunits NDUFS2, NDUFS7, ND3 and ND1 [Sazanov, 2015]. The 
size of this site is large enough to accommodate an entire quinone molecule. The quinone 
binding site is mostly constituted by hydrophilic residues which guide the head of the 
quinone to bind in the deep end of the cavity, about 15 Å out from the membrane surface 
[Baradaran et al., 2013]. 
 
 
 
Figure 1.8 Schematic human CI assembly [Mimaki et al., 2012]. 
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Table 1.1 CI core subunits nomenclature. 
 
For each molecule of oxidized NADH, four protons are transported across the 
membrane to the inter-membrane space [Hirst, 2013]. Two set of five helices in ND2, 
ND3 and ND5 subunits of the membrane-arm have been proposed to form channels for 
proton translocation. The channels are constituted by conserved polar residues and polar 
cavities containing water molecules [Baradaran et al., 2013]. The key residues involved in 
proton translocation are the conserved Lys and Glu residues of the helices 5, 7, 8 and 12 
[Sazanov, 2015]. The electron transport from the FMN through the Fe-S cluster chain 
causes a cascade of conformational changes in the peripheral-arm which are propagated 
into membrane-arm where the key residues of ND2, ND3 and ND5 are protonated. When 
the quinone is totally reduced and the conformational changes are completed, the key 
residues eject a proton across the membrane [Baradaran et al., 2013; Hirst, 2013; Sazanov, 
2015]. 
 
1.3.2 Complex II 
Mitochondrial CII (succinate:ubiquinone oxidoreductase or succinate 
dehydrogenase, SDH; EC 1.3.5.1) is the only respiratory complex totally encoded by 
nuclear DNA [Her and Maher, 2015; Sun et al., 2005]. CII is also the only membrane 
Module Thermus thermophilus Bos taurus Homo sapiens
Nqo1 51 kDa NDUFV1
Nqo2 24 kDa NDUFV2
Nqo3 75 kDa NDUFS1
Nqo4 49 kDa NDUFS2
Nqo5 30 kDa NDFUS3
Nqo9 TYKY NDUFS8
Nqo6 PSST NDUFS7
Nqo8 ND1 ND1
Nqo7 ND3 ND3
Nqo10 ND6 ND6
Nqo11 ND4L ND4L
Nqo14 ND2 ND2
Nqo13 ND4 ND4
Nqo12 ND5 ND5
P
Table 1.1 Complex I core subunits nomenclature
Peripheral arm
N
Q
Membrane arm
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complex of the Krebs cycle, catalyzing the oxidation of succinate to fumarate in the 
mitochondrial matrix and producing one molecule of FADH2. Succinate oxidation is 
coupled to reduction of quinone to quinol at the inner membrane as one part of the 
respiration electron transfer chain. Electrons are transferred from succinate to quinone 
through the prosthetic groups flavin-adenine dinucleotide (FAD), the [2Fe-2S], [4Fe-4S], 
and [3Fe-4S] clusters, and a b-type heme, which form an integral part of the complex [Her 
and Maher, 2015]. 
CII was crystallized from porcine heart in 2005 by Sun and colleagues [Sun et al., 
2005]. SDH is a 124 kDa complex which consists of a soluble catalytic heterodimer and an 
integral membrane region, resembling a Q-shaped structure (Figure 1.9) [Sun et al., 2005]. 
The hydrophobic domain is composed by SDHC and SDHD subunits which anchor the 
complex to the inner membrane. The hydrophilic domain, protruding into the matrix, is 
formed by SDHA and SDHB subunits. SDHA contains the binding site for succinate and a 
FAD prosthetic group covalently bound. Succinate is juxtaposed with the isoalloxazine ring 
of FAD, where oxidation to fumarate is catalyzed. SDHB connects SDHA to SDHC and 
SDHD. SDHB contains three Fe-S clusters: [2Fe-2S], [4Fe-4S], and [3Fe-4S], which 
mediate electron transfer from succinate to ubiquinone. The complex has two quinone-
binding sites: i) the high-affinity site (Qp), formed by residues from SDHB, SDHC, and 
SDHD subunits and located near the matrix side of the inner mitochondrial membrane; ii) 
and the low-affinity site (Qd), formed by SDHC and SDHD subunits and located on the 
inter-membrane space side. Both the quinone binding pockets are constituted by a long 
hydrophobic channel formed by helices of the involved subunits. Between four bound 
helices of SDHC and SDHD subunits, a b heme group is found. It is stabilized by 
hydrophobic interaction between the porphyrin group and the four helices [Her and 
Maher, 2015; Sun et al., 2005]. 
Despite being formed by 4 subunits only, CII assembly is very intricate and 
several chaperones are needed to help the protein folding and the factor insertion [Her and 
Maher, 2015]. The SDHA assembly process requires the insertion of FAD. FAD is 
imported in mitochondria from cytosol through Flx1 protein at the inner membrane, being 
a member of the superfamily of mitochondrial carriers that exchange substrates between 
the cytosol and the matrix [Robinson and Kunji, 2006]. SDHAF2 is necessary for the 
covalent insertion of FAD into the catalytic SDHA subunit [Hao et al., 2009]. SDHAF1 
and SDHAF3 allow the insertion of Fe-S clusters into SDHB subunits [Ghezzi et al., 2009; 
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Na et al., 2014]. SDHAF4 is required for the association of SDHA to SDHB and the 
consequent assembly of CII holocomplex [Van Vranken et al., 2014]. The tcm62 gene 
encodes a mitochondrial membrane protein that was shown to directly interact with three 
SDH subunits helping the folding of CII [Dibrov et al., 1998]. 
 
 
Figure 1.9 Structure of porcine CII. SDHA-B-C-D subunits, Fe-S clusters, FAD, b heme group and the 
quinone are indicated [from Her and Maher, 2015]. 
 
The catalytic mechanism of SDH starts at the binding site of the succinate. The α-
carbon of succinate is deprotonated by basic residues or cofactors, FAD accepts hydride 
from the β-carbon and the succinate is oxidized to fumarate. Oxidized fumarate is free to 
exit the protein and a FADH2 molecule is released. The electrons derived from the 
succinate oxidation are carried along the Fe-S clusters until [3Fe-4S] center where they are 
transferred to quinone bound in its site. The reduction pathway of the quinone requires 
two electrons to fully reduce quinone to quinol. The first electron forms a quinone 
intermediate, a semiquinone radical specie, the second electron from the [3Fe-4S] center 
provides to reduce the semiquinone to ubiquinol [Sun et al., 2005]. 
The activity of SDH is highly regulated by succinate competitors, ubiquinone 
inhibitors, or post-translational modifications [Her and Maher, 2015]. Malonate, malate, 
and oxaloacetate are succinate competitors, being similar in structure. Carboxin and 
thenoyltrifluoroacetone are synthetic ubiquinone inhibitors that block electron transfer 
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from the SDH complex to ubiquinone [Her and Maher, 2015]. The catalytic activity of the 
complex is also modulated by post-translational modifications such as phosphorylation and 
acetylation of SDHA lysine residues. The acetylation of SDHA lysine decreases the activity 
of CII [Cimen et al., 2010; Finley et al., 2011]. Phosphorylation of SDHA lysine residues has 
similar effects of the acetylation on SDH activity [Tomitsuka et al., 2009]. Recently, Acín-
Pérez and colleagues found that the tyrosine 604 phosphorylation of SDHA subunit 
strongly increases the CII activity [Acín-Pérez et al., 2014]. Moreover, succinylation of 
SDHA lysine residues has been reported, this modification possibly modulating the SDH 
activity [Park et al., 2013]. 
 
1.3.3 Complex III 
Respiratory CIII (ubiquinol:cytochrome c oxidoreductase, cytochrome bc1 
complex; EC 1.10.2.2) is the central component of the mitochondrial respiratory chain, 
coupling the transfer of electrons from quinol to cytochrome c with the generation of a 
proton gradient across the inner membrane [Bénit et al., 2009]. 
The mammalian CIII is an homodimeric enzyme (CIII2), with each monomer 
consisting of 11 polypeptide subunits, one encoded by mitochondrial genome and ten 
encoded by nuclear genes. The catalytic center is formed by three redox essential subunits: 
cytochrome b, cytochrome c1 and the Fe-S protein (Rieske protein, ISP). Cytochrome b 
contains two b-type hemes, a low potential heme bL (Em7 = − 30 mV) and a high potential 
heme bH (Em7 = + 100 mV); cytochrome c1 has a globular domain which binds a c-type 
heme group (Em7 = + 230 mV for bovine CIII) and the Rieske protein also contains a 
globular domain with two 2Fe-2S iron-sulfur cluster whose iron atoms are ligated by two 
cysteine and two histidine residues. The exact function of the other eight supernumerary 
subunits (UQCRC1, UQCRC2, UQCRH, UQCRB, UQCRQ, Subunit 9, UQCR10 and 
UQCR11) remains to be established, their possible functions include structural stability and 
regulation of coordinated activity of the dimeric enzyme [Xia et al., 2013].  
Structures of CIII from several organism are available, including the bovine heart 
mitochondria, which was the first obtained [Iwata et al., 1998; Xia et al., 1997]. CIII 
structure can be divided into three regions: the membrane spanning, the inter-membrane 
and the matrix region. Each monomer of CIII is composed by 13 trans-membrane helices: 
eight from cytochrome b and one each from cytochrome c1, the ISP, subunits 7, 10, and 11. 
Accessory subunits 1, 2, 6 and 9 are exclusively present in the matrix region, while subunit 
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8 is associated with cytochrome c1 at the inter-membrane space side [Iwata et al., 1998; Xia 
et al., 1997]. The two b-type hemes of cytochrome b are part of the active sites that catalyze 
opposite reactions: the QP (QO near bL heme; O, outer; P, positive) site, located near the 
inter-membrane space, provides access to lipid-soluble QH2 for oxidation, and the QN (QI 
near bH heme; I, inner; N, negative) site, situated close to the matrix, is involved in the 
reduction of ubiquinone. Both the cytochrome c1 and ISP subunits are anchored to the 
membrane by trans-membrane helices with their respective extra membrane domains 
localized on the inter-membrane space. The globular domain of the Rieske protein is 
attached to a membrane-spanning helix and appears to be able to rotate so that its Fe–S 
centre can contact either the quinone-binding site or the c-type heme of cytochrome c1 
(Figure 1.10) [Xia et al., 2013]. 
 
 
Figure 1.10 Crystallographic structure of bovine CIII. The three regions with their subunits are indicated 
[from Iwata et al., 1998]. 
 
The proton extrusion mechanism at CIII is quite unique, since ubiquinol is used 
to shuttle protons across the membrane via the so called Q-cycle [Mitchell, 1976]. The Q-
cycle requires a quinol oxidation site and a quinone reduction site and the oxidation of two 
quinol molecules to complete one cycle. In the first half of the Q-cycle, a QH2 moves into 
the QP site, formed when the globular domain of the ISP rotates allowing the binding of 
QH2 by bridging residues of both proteins. QH2 undergoes oxidation with one electron 
arriving to cytochrome c via the ISP and cytochrome c1 and the other going to hemes bL. 
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The electron on bL moves across the membrane to reduce the second heme bH and finally 
the quinone bound in the QN site, forming a semiquinone radical (Q˙
-). This pathway 
releases two protons in the inter-membrane space. In the second half of the Q-cycle, a 
second QH2 is oxidized in the same way at the QP site, reducing completely the Q˙
- at QN 
site. The fully reduced QH2 , upon taking up two protons from the matrix, moves through 
the membrane to the QP site to be oxidized. Thus, as a result of the Q-cycle, four protons 
are transferred to the inter-membrane space, two protons are taken up from the matrix, 
two quinol molecules are oxidized and one quinone is reduced (Figure 1.11) [Xia et al., 
2013]. 
 
Figure 1.11 Representative scheme of the Q-cycle. 
 
Table 1.2 Nomenclature of the bovine and yeast CIII subunits. 
Subunit Gene Protein Gene Protein
1 UQCRC1 Core I QCR1 Cor1
2 UQCRC2 Core II QCR2 Cor2
3 MTCYB Cytochrome b COB COB
4 CYC1 Cytochrome c1 CTC1 Cyt1p
5 UQCRFS1 ISP-Rieske Protein RIP1 Rip1p
6 UQCRB SU8 QCR7 Qcr7p
7 UQCRQ SU7 QCR8 Qcr8p
8 UQCRH SU8 QCR6 Qcr6p
9 UQCR10 SU10 QCR9 Qcr9p
10 UQCR11 SU11 QCR10 Qcr10p
11 - SU9* - -
SU9*
Table 1.2 The bovine and yeast CIII subunits
Mitochondrial targeting presequence cleaved from UQCRFS1
Saccharomyces cerevisiaeBos taurus
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CIII assembly has been mainly studied in the yeast Saccharomyces cerevisiae [Atkinson 
et al., 2010; Cui et al., 2012; Gruschke et al., 2011, 2012; Hildenbeutel et al., 2014; Smith et al., 
2012; Zara et al., 2007, 2009a, 2009b]. A model of the human CIII assembly, based on the 
data obtained from yeast, has been recently proposed by Fernández-Vizarra and Zeviani 
(Figure 1.12) [Fernández-Vizarra and Zeviani, 2015]. The initial step is the release of 
cytochrome b from the mito-ribosome and its insertion into the inner membrane, a process 
that requires the two assembly factors, UQCC1 and UQCC2. The UQCC1-UQCC2 
complex remains bound to cytochrome b once it is completely synthesized and 
incorporated into the inner membrane. Once bL type heme is inserted into the catalytic 
center of cytochrome b, UQCC3 binds followed by bH type heme incorporation. The 
UQCC1-UQCC2 dimer is released when UQCRB and UQCRQ bind to cytochrome b, to 
form the early-stage CIII intermediary. Additional subunits, i.e., UQCRC1, UQCRC2, and 
CYC1 are then incorporated, followed by UQCRH and later UQCR10, to form pre-CIII2. 
At this point, the complex is already dimeric, but the precise stage at which dimerization 
occurs is currently unknown. Finally, UQCRFS1 (Rieske protein) is translocated from the 
matrix into the inner membrane and is incorporated into pre-CIII2, operated by the 
assembly factor, BCS1L. In the matrix, UQCRFS1 is bound and stabilized by MZM1L. 
Finally the last subunit (UQCR11) joins the nascent complex, so that assembly is 
completed. TTC19 is also necessary for the correct biogenesis of CIII2 in human 
mitochondria, although the step in which it intervenes is not known yet. The nomenclature 
used is for the human/bovine, for the yeast nomenclature see the Table 1.2 [Fernández-
Vizarra and Zeviani, 2015]. 
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Figure 1.12 Human CIII assembly model [from Fernández-Vizarra and Zeviani, 2015]. 
 
1.3.3.1 Cytochrome b 
The cytochrome b is the only CIII subunits encoded by mtDNA. It is a highly 
conserved membrane protein 380 amino acid residues long in human CIII [Iwata et al., 
1998; Xia et al., 1997]. The MTCYB gene encompasses 1140 nps of mtDNA and encodes a 
single polypeptide. The mRNA has a 4-np, 5-prime noncoding region followed by the 
AUG start codon, and ends with the U of the UAA termination codon. It is transcribed as 
a part of the polycistronic H-strand transcript, flanked by the tRNAGlu and tRNAThr 
transcripts. These tRNAs are clove out at the transcript freeing transcript 11, the 
cytochrome b mRNA. The mRNA is then polyadenylated completing the termination 
codon [Wallace, 1989]. The translation of the mitochondrial genome encoded subunit was 
first studied by Gruschke and colleagues in yeast. Cytochrome b pre-mRNA is processed 
by matrix protein Cbp2, then translation is activated by the mitochondrial proteins Cbs1 
and Cbs2, that interact with 5’ untranslated region, allowing the transcript to begin its 
translation by mito-ribosomes. The newly synthesized protein binds to a complex formed 
by the translational activator Cpb6 (UQCC1 in human) and the matrix assembly protein 
Cpb3. This assembly complex recruits another assembly factor Cpb4 (UQCC2 in human), 
Introduction 
25 
 
altogether stabilize the newborn subunit while it receives its cofactors and forms 
interactions with additional CIII subunits [Gruschke et al., 2011]. 
When folded, the protein is formed by eight trans-membrane helices named A-H 
with both of the N- and the C-terminus located in the matrix. The trans-membrane helices 
are linked by seven extra-membrane loops, five of which are prominent: the AB, CD, DE, 
and EF protrude into the inter-membrane space, while the DE loop projects towards the 
matrix side. These loops are the primary participants in the formation of the QO and QI 
site, thus, they are crucial for the function of cytochrome b. The AB, CD and EF loop have 
secondary structure: AB and EF loop contain one helix each, ab helix for AB loop and ef 
helix for EF; the CD loop is formed by two helices, cd1 and cd2, arranged as hairpin. 
Between the helices E and F, in the EF loop, the PEWY sequence is located. This 
sequence is highly conserved, containing P270-E271-W272-Y273 in the bovine, and it seems to 
be important for electron transfer and quinol binding at the Qo site. The eight helices form 
two helical bundles, one consisting of helices A−E and the other of helices F−H. The bL 
and bH hemes are incorporated into the first helical bundle, bound to conserved histidine 
residues (H83 and H182 for bL, H
97 and H196 for bH). The two helical bundles are separated 
from each other near the inter-membrane space side of the membrane, thus creating the 
so-called QO pocket between the bL heme and the 2Fe−2S cluster of the Rieske protein. 
Near the bH another hydrophobic pocket is formed, the QI site (Figure 1.13). The two 
bundles contact each other on the negative side of the membrane, but separate on the 
positive side, creating a gap that is bridged by the cd helices (cd1 and cd2) and by the EF 
loop [Gao et al., 2003; Iwata et al., 1998; Xia et al., 1997]. 
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Figure 1.13 Schematic representation of cytochrome b. The quinone binding sites (QI and QO) and the bH 
and bL are indicated. The trans-membrane helices are indicated A-H [from Gao et al., 2003]. 
 
1.3.4 Complex IV 
CIV (cytochrome c oxidase, COX; EC.1.9.3.1) catalyzes the electron transport 
from cytochrome c to oxygen coupled to proton pumping across the mitochondrial 
membrane. In mammals CIV is a homodimer, each half comprising 13 subunits. Three of 
these subunits (I-III) form the catalytic core and are encoded by mtDNA, whereas the 
remaining ten subunits (IV, Va, Vb, VIa, VIb, VIc, VIIa, VIIb, VIIc, VIII) encoded in the 
nucleus, are tightly bound to I-III subunits. The nuclear-coded subunits are essentially 
involved in the regulation of oxygen consumption and proton translocation by CIV 
[Kadenbach and Hüttemann, 2015]. 
The CIV structure from bacteria [Iwata et al., 1995] and bovine [Tsukihara et al., 
1996] is known. Subunit II has two membrane-spanning α-helices and a large globular 
hydrophilic domain forming a docking surface for cytochrome c. It also contains a 
bimetallic copper center, CuA, providing the entry point for the electrons. Subunit I is the 
largest of the catalytic core subunits. It is composed of 12 trans-membrane helices arranged 
in groups of four around three cavities. The first of these cavities contains an a-type heme, 
heme a, bound to two histidine residues. In the second cavity, the oxygen reduction site is 
present, formed by a second a-type heme, heme a3, and the histidine-bound copper, CuB. 
The heme a3 iron is bound to a histidine residue on its proximal side, whereas on the distal 
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side the iron faces the CuB. This site is often called binuclear centre (BNC), due to the 
presence of two metals. The histidine bound to CuB and a close tyrosine residue, involved 
in the catalysis, create a covalent link, producing a pentameric ring with the highly 
conserved sequence HPEVY. The crystal structure revealed three possible proton-transfer 
pathways. One of these, named the “K” channel from a conserved lysine residue, Lys319, 
leads from the matrix towards the BNC. A second, named the “D” channel from an 
aspartate residue, Asp91, near its entrance, leads from the matrix to a conserved glutamic 
acid residue (Glu242) that is in the middle of the pentameric HPE242VY ring sequence. An 
additional possible proton channel, the “H” channel, has been described in the bovine 
structure leading from the matrix towards heme a (Figure 1.14) [Kadenbach and 
Hüttemann, 2015; Rich and Maréchal, 2010; Tsukihara et al., 1996]. 
 
Figure 1.14 Crystal structure of dimeric CIV from bovine heart [modified from Tsukihara et al., 1996]. The mt-
DNA-coded subunit I, II and III are in yellow, the other subunits are in colors. 
CIV reduces molecular oxygen to water in the O2-reduction site composed of Fea3 
and CuB. This mechanism requires the sequential arrival of four electrons and four protons. 
O2 is bound to the O2-reduction site when both metal sites are in the reduced state (Fea3
2+ 
and CuB
1+). The fully reduced state is designated as the R-intermediate. The R-intermediate 
receives O2 to form Fea3
3+-O2
− (the A-intermediate), which is spontaneously converted to 
the P-intermediate without any electron transfer from the low-potential metal sites (Fea and 
CuA). By the time P has formed, the
 bound O2 has accepted four electron equivalents (two
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equivalents from Fea3, one from CuB, and the fourth from a
 nearby tyrosine OH). In the 
resulting P-intermediate, an oxide (O2−) and a hydroxide (OH−) are bound to Fea3 and CuB,
 
respectively. Next, the P-intermediate receives four electron equivalents from cytochrome c 
via the low-potential metal sites, CuA and Fea (heme a). These equivalents are added one at 
a time, forming the F-, O-, and E-intermediates and ultimately reproducing the R-
intermediate [Yamashita and Voth, 2012; Yoshikawa et al., 2012; Yoshikawa and Shimada, 
2015]. 
The assembly pathway of CIV has been extensively studied in human [Nijtmans et 
al., 1998; Williams et al., 2004] and yeast [Barrientos et al., 2004; Horan et al., 2005], showing 
that it is very conserved between these organisms, still highlighting the important role of 
yeast as a model for human proteins [Fontanesi et al., 2006]. Cox2 is translated as a 
precursor (pCox2) with a N-terminal 15 amino acids extension. It is transported across the 
membrane and kept in an assembly-competent state by Cox20. Next, Cox1 assembles with 
the first nuclear-encoded subunits, Cox6 and Cox5. Cox2 is further processed with copper 
insertion, a necessary prerequisite for the association with the Cox1–Cox5–Cox6 complex. 
The next step is the association of Cox2 or Cox3 with the Cox1–Cox5–Cox6 complex, it is 
unknown whether Cox2 is the first subunit associated or it is Cox3. Cox7, Cox8 and Cox9 
form a complex prior to their incorporation, mediated by Pet100. The incorporation of 
Cox12 and Cox13 closes the complex biogenesis (Figure 1.15). See Table 1.3 for the 
nomenclature in mammals [Mick et al., 2011; Soto et al., 2012]. 
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Figure 1.15 Schematic representation of the CIV assembly pathway [from Mick et al., 2011].  
 
Table 1.3 Nomenclature of yeast and mammals CIV subunits. 
Yeast Mammals
Cox1 COX1 or MTCO1
Cox2 COX2 or MTCO2
Cox3 COX3 or MTCO3
Cox4 COX5b
Cox5a and b COX4-1 and -2
Cox6 COX5a
Cox7 COX7a
Cox8 COX7c
Cox9 COX6c
Cox12 COX6b
Cox13 COX6a
- COX7b
- COX8
mtDNA encoded subunits
nDNA encoded subunits
Table 1.3 Nomenclature of CIV subunits
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1.4 Reactive oxygen species production by respiratory complexes 
The free radical is defined as a chemical specie, an atom or molecule, that has one 
or more unpaired electrons in valance shell and is capable of existing independently. It can 
react quickly with other compound, trying to capture the needed electron to gain stability. 
Generally, free radical attacks the nearest stable molecule, “stealing” its electron [Vishal-
Tandon et al., 2005]. 
The most important free radicals in biological systems are those deriving from 
partial oxygen reduction. Reactive oxygen species (ROS) are a collective term including 
oxygen derivatives, either radical or non-radical, that are oxidizing agents and/or are easily 
converted into radicals. If a single electron is supplied to O2, the superoxide radical anion 
O2·
- is formed. Addition of another electron to O2·
- gives the peroxide ion, which is a weak 
acid that can be protonated to hydrogen peroxide H2O2. Addition of two more electrons 
splits the molecule producing water H2O. If one single electron is added to H2O2 by a 
reduced metal ion (e.g., Fe2+), the hydroxyl radical OH• is produced by the Fenton 
reaction. The hydroxyl radical is extremely reactive with a half-life of less than 1ns, thus it 
reacts close to its site of formation [Genova and Lenaz, 2015].  
ROS can increase in cells from exogenous and endogenous sources. Exogenous 
sources of ROS include UV and visible light, ionizing radiation, drugs, and environmental 
toxins. Among endogenous sources are many enzymes including the mitochondrial 
respiratory complexes [Genova and Lenaz, 2015]. In fact the electron transport chain has 
been recognized as one of the major cellular generators of ROS. In particular, the 
respiratory CI, CII, and CIII are known to generate ROS through the leak of electrons to 
molecular oxygen (Figure 1.16) [Hamanaka and Chandel, 2010]. CI has been considered 
one of the main sites of production of ROS, as also confirmed by recent studies showing 
that electron leak at CI can release single electrons to oxygen and give rise to the 
superoxide anion in several types of mitochondria [Lenaz and Genova, 2010]. It is well 
known that superoxide production by CI is higher during the reverse electron transport 
from succinate to NAD+, whereas during the forward electron transport, it is much lower 
[Jezek and Hlavatá, 2005]. Rotenone enhances ROS formation during forward electron 
transfer and inhibits it during reverse electron transfer [Ohnishi et al., 2005]. Several 
prosthetic groups in the complex have been suggested to be responsible of direct oxygen 
reduction, such as FMN [Esterházy et al., 2008], the Fe-S cluster N2 [Fato et al., 2009] and 
the quinone-binding site [Ohnishi et al., 2005]. Also CII is a signiﬁcant source of ROS 
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either directly, presumably by electron leak from FAD [Moreno-Sánchez et al., 2013] or 
indirectly through reverse electron transfer from succinate to quinone and back to CI. ROS 
release by reverse electron transfer primarily occurs at sites upstream of the rotenone 
inhibition site, as indicated by the prevention of this formation by rotenone. Furthermore, 
reverse electron transfer is strongly stimulated by high ΔΨ, which thermodynamically 
allows electron donation from CII to CI [Hirst et al., 2008; Quinlan et al., 2012]. The 
formation of superoxide in CIII depends on this peculiar mechanism of electron transfer. 
Since the electron transfer from cytochrome bL to bH occurs against the electrical gradient, it 
is strongly retarded when the electrochemical potential is high. This delay prolongs the 
lifetime of QO, allowing reaction of the semiquinone with O2, with superoxide formation. 
Antimycin A, by blocking quinone reduction by cytochrome bH at QI [Jezek and Hlavatá, 
2005] also enhances the superoxide production. More recent evidence, however, suggests 
that the source of the electron to reduce oxygen is the semiquinone formed in the so-called 
semi-reverse reaction in which cytochrome bL reduces the fully oxidized quinone. In fact, 
superoxide formation is stimulated by the presence of oxidized quinone [Dröse and 
Brandt, 2008] and by mutations preventing the proximity of the Fe-S cluster of the Rieske 
protein to the ubiquinone site. This latter condition does not allow an interaction of 
semiquinone with the Rieske cluster and thus favors its reaction with oxygen [Lanciano et 
al., 2013; Sarewicz et al., 2010]. 
 
 
 
Figure 1.16 Scheme of superoxide production by CI, CII and CIII [from Hamanaka and Chandel, 2010]. 
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ROS are recognized either as important physiological intracellular signals, affecting 
the redox state of signaling proteins, and as the major determinants of toxicity in cells and 
organisms [Genova and Lenaz, 2015]. Indeed, at moderate concentrations ROS act as 
second messengers by interfering with the expression of a number of signal transduction 
pathways and genes. Many of the ROS-mediated responses actually protect the cell against 
oxidative stress and re-establish redox homeostasis. Because ROS are oxidants, they 
directly influence the redox state of signaling proteins and are suitable for signal 
transduction. ROS are associated with positive (cell proliferation) or negative responses 
(cell death). At high concentrations, their accumulation causes oxidative damage within 
cells. As oxidative damage we intend several modifications which are accumulating with 
aging, such as protein carbonylation and methionine oxidation, advanced glycation end-
products (AGE), lipid peroxidation, and nucleotide modifications. The damage caused by 
ROS strictly depends on their reactivity. Free radicals can meet each other forming non-
radical products or products even more dangerous. A radical can meet a non-radical species 
generating a new radical and initiating a chain reaction [Lenaz, 2012]. 
The deleterious effects resulting from ROS overproduction at mitochondrion are 
prevented by various enzymes and non-enzymatic antioxidant systems. Among the 
antioxidant enzymes, the superoxide dismutase (SOD) scavenger enzymes convert 
superoxide radicals into H2O2 and molecular oxygen. There are three SOD enzymes 
expressed in mammalian cells. MnSOD is the mitochondrial antioxidant that exists in 
homotetramers and localizes in the mitochondrial matrix [Candas and Li, 2014]. The 
resultant H2O2 is largely removed by catalase, glutathione peroxidases and peroxiredoxins 
(Prx). Catalase converts H2O2 into O2 and H2O. It is localized in peroxisomes but it has 
been detected also in mitochondria of heart and liver of rat. Glutathione peroxidase is the 
mitochondrial enzyme that utilizes glutathione (GSH) for the reduction of H2O2 to H2O. 
Two main forms of glutathione peroxidase exist. The selenoenzyme can be detected in 
various cellular compartments including the mitochondrial matrix and inter-membrane 
space. Mitochondrial GSH is important for the maintenance of the appropriate 
mitochondrial redox environment to avoid or repair oxidative modifications. GSH must be 
regenerated by glutathione reductase (GR) using NADPH as the reductant [Lenaz, 2012]. 
Peroxiredoxins (Prxs) are a family of enzymes that catalyze the reduction of hydrogen 
peroxide to water. There are six isoforms of Prxs, categorized by their subcellular 
localization. Prx3 is the isoform found in the mitochondrial matrix together with the Prx5 
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[Song et al., 2011]. Among the non-enzymatic antioxidant system, there are different 
molecules such as vitamin C, vitamin E, coenzyme Q, GSH, as introduced above, lipoic 
acid, uric acid, carotenoids and flavonoids [Lenaz, 2012]. 
 
1.5 The respiratory supercomplexes 
How respiratory complexes are organized in the inner membrane has been an 
object of intense studies. Chance and Williams were the first to represented the respiratory 
chain as a solid-state assembly of coenzymes and cytochromes in a protein matrix, with 
electron transfer occurring between enzymes in very close proximity [Chance and Williams, 
1955] and, in 1962, Hatefi observed that CI and CIII preferentially associated during 
purification of mitochondrial membrane [Hatefi et al., 1962]. Much later, Hackenbrock 
proposed the fluid or random collision model for the organization of the respiratory chain 
[Hackenbrock et al., 1986]. In this model, the respiratory complexes are viewed as 
independent entities embedded in the inner membrane, with CoQ and cytochrome c acting 
as mobile carriers that freely diffuse in the lipid membrane. The random collision model 
became a widely accepted model for the respiratory chain organization until seminal studies 
performed in 2000 in mammals and yeast introduced the use of blue native gel 
electrophoresis (BN-PAGE) to analyze the migration of native protein complexes in 
digitonin-solubilized mitochondrial membranes [Schägger and Pfeiffer, 2000] and their co-
purification by sucrose-gradient centrifugation [Eubel et al., 2004]. These observations led 
to a reformulation of the solid model, proposing that respiratory complexes are indeed 
organized in large structures named respiratory supercomplexes (SCs) [Acín-Pérez et al., 
2004; Schägger and Pfeiffer, 2000]. 
Very recently, this model has been implemented in the “plasticity model”, 
showing that the individual complexes and SCs can coexist within the inner membrane, 
depending on the different organisms and on the particular metabolic requirements of the 
cells [Lapuente-Brun et al., 2013]. By monitoring the oxygen consumption in mitochondria 
in the presence of pyruvate plus malate and succinate together or separately, an additive 
effect on the respiratory activity was observed when both substrates are present. This effect 
was not detected when CIII2+IV were not assembled [Lapuente-Brun et al., 2013]. 
Furthermore, it was proposed that the quite huge amount of CoQ present in the inner 
membrane exists at least as two distinct pools: one dedicated to NADH- and the other one 
to FAD-dependent enzymes. Conversely, cytochrome c is common to both NADH and 
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FADH enzymes, but it can be found associated with the SCs and also as a pool providing 
electrons to the free CIV [Enriquez and Lenaz, 2014]. However, the existence of these Q 
pools has been questioned by the Hirst’s group, suggesting the presence of a single Q pool, 
since they failed to observe any additive effect by fuelling the respiratory activity with 
different substrates. These authors indeed reported a competition between CI and CII for a 
common Q pool [Blaza et al., 2014].  
 
1.5.1 Structural organization of SCs 
During the last years BN-PAGE has been widely used to evaluate the 
organization of the respiratory complexes, revealing the existence of respiratory SCs in 
many different systems such as bacteria, fungi, higher plants mitochondria and mammals 
mitochondria, and suggesting that their organization in supra-molecular assemblies is a 
common and advantageous feature for OXPHOS systems [Ghelli et al., 2015]. CI, CIII and 
CIV can associate in three types of SCs (see Figure 1.17). CI can associate with a CIII 
dimer to form the I+III2 supercomplex, which is mainly found in plant mitochondria 
[Bultema et al., 2009; Dudkina et al., 2005a; Peters et al., 2008]. Electron microscopy analysis 
revealed that the CIII2 is laterally attached to the membrane arm of CI in its concave 
portion. In plants and yeast, CIII2 was found to associate with one or two copies of CIV. 
The detailed EM analysis revealed that the CIII2 is flanked from both sides by monomeric 
CIV [Bultema et al., 2009; Dudkina et al., 2006; Heinemeyer, et al., 2006; Heinemeyer et al., 
2007; Krause et al., 2004]. The largest respiratory chain supercomplex is formed by CI, 
CIII2 and up to 4 copies of CIV. This is called the respirasome because it represents the 
minimal unit able to perform complete respiration from NADH to oxygen [Schägger and 
Pfeiffer, 2000]. Studies on bovine respirasome demonstrated that CIII2 sits in the arc of the 
membrane arm of CI while CIV is attached to the tip of NADH dehydrogenase [Althoff et 
al., 2011; Chaban et al., 2014; Dudkina et al., 2011]. Furthermore, there are suggestions that 
even higher levels of organization may exist (megacomplexes or respiratory strings) which 
seem to be important for the morphology of the inner mitochondrial membrane [Bultema 
et al., 2009; Genova and Lenaz, 2014; Wittig and Schägger, 2008]. CII and CV were never 
found associated with other respiratory complexes [Genova and Lenaz, 2014], with the 
exception of mitochondria from mouse tissues [Acín-Pérez et al., 2008]. Furthermore, 
Acín-Pérez and colleagues were able to directly measure the NADH oxidase activity of 
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bands excised from BN-PAGE by using a Clark electrode, demonstrating that the 
respirasomes, enriched in CoQ and cytochrome c, exhibit respiratory activity and therefore 
must provide some advantage in electron transfer [Acín-Pérez et al., 2008]. 
 
Figure 1.17 SCs I-III-IV, I-III, III-IV and free complexes in the inner mitochondrial membrane. 
 
1.5.2 Advantages of SCs organization  
The organization in macromolecular assemblies is predicted to provide functional 
advantages to the mitochondrial respiratory function [Ghelli et al., 2015]. 
It was speculated that the specific interaction between complexes to form SCs 
enhances either electron flow between the enzymes by direct channeling of ubiquinone and 
cytochrome c and catalysis of the enzymes. Evidence for this hypothesis derives from the 
3D structure of the I+III2+IV1 SC of bovine mitochondria obtained by electron cryo-
microscopy, showing that the quinon-binding sites in CI and in CIII face each other 
[Althoff et al., 2011]. On the other hand, demonstration of cytochrome c channeling is 
more controversial because of the experimental difficulties to test its functional role in 
CIII2+IV SC, although a portion of CIV has been recently reported to allow the channeling 
of cytochrome c [Lapuente-Brun et al., 2013]. 
It has been proposed that SCs can limit the extent of superoxide generation by CI 
and CIII during the electron transfer, reducing the amount of electron leakage, as well as 
the sequestering of vulnerable sites which protects the complexes from oxidative damage. 
Indeed, a tighter organization of isolated complexes in SCs may protect auto-oxidizable 
prosthetic groups, preventing their reaction with oxygen. In accord with this view, it has 
been recently demonstrated that after impairing the SCs formation, ROS production by CI 
was strongly increased, suggesting that CI and CIII association prevents superoxide 
generation [Maranzana et al., 2013]. This is in agreement with the recent finding that 
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MnSOD directly interacts with the I+III2+IV SC, protecting it from oxidative damage 
[Suthammarak et al., 2013]. 
Finally, the supercomplex organization seems to be relevant for preserving the 
stability of CI. It was proposed that CI is bound to CIII under physiologic conditions to 
preserve its structural integrity and activity [Schägger et al., 2004]. This hypothesis is 
supported by studies performed by using in vitro and in vivo models with mutations on the 
respiratory complexes. Indeed, CI was shown to be very unstable in absence of CIII in 
mice-derived cells [Acín-Pérez et al., 2004] and to be stabilized by CIII in NDUFS4 subunit 
knock-out mice [Calvaruso et al., 2012]. Furthermore, the assembly of CI was defective in 
cells lacking CIII or CIV [D’Aurelio et al., 2006; Diaz et al., 2006; Diaz et al., 2012; Li et al., 
2007]. Moreover, it has been reported that dysfunction in CI can destabilize CIII [Budde et 
al., 2000], but this view is still controversial [Acín-Pérez et al., 2004; Li et al., 2007]. 
 
1.5.3 SCs assembly and their assembly factors 
In the last years, understanding the mechanism of SCs assembly has been the 
central point of research. So far, two models of SCs assembly have been proposed (Figure 
1.18) [Porras and Bai, 2015; Vartak et al., 2013]. The first one hypothesized that SCs 
assembly follows the assembly of individual respiratory complexes. Indeed, labeling of 
mitochondrial translational products indicated that there is sequential incorporation of 
mtDNA-encoded subunits into respective complexes followed by SC assembly [Acín-Pérez 
et al., 2008]. In contrast, studies in Neurospora Crassa showed that CIII2+IV can assemble 
separately from CI, after that, CIII and CIV interact with the membrane arm of CI, this 
interaction being important for full assembly of CI [Marques et al., 2007]. Recently, 
Moreno-Lastres and colleagues provided support to this mechanism by depleting the 
OXPHOS complexes after cell treatment with doxycycline and then monitoring the 
assembly of complexes by BN-PAGE. It was shown that CI can assemble independently of 
the 830 kDa, a CI subassembly lacking the NADH dehydrogenase module and additional 
subunits. At this point CIII and then CIV subunits start binding to the membrane arm of 
CI, being required for incorporation of the remaining CI catalytic subunits NDUFS4 and 
NDUFV1. These observations suggested that the SCs assembly precedes the assembly of 
individual respiratory complexes [Moreno-Lastres et al., 2012]. 
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Figure 1.18 Schematic representation of two possible pathways of SCs assembly and the assembly factors 
involved [from Porras and Bai, 2015].  
 
Recently, many research groups focused their interest on SCs assembly factors. 
Several assembly factors for individual CI, CIII and CIV have been identified. Concerning 
the SCs, two hypotheses have been proposed: i) the presence of exclusive assembly factors 
that help SCs assembly after individual complexes have been completely assembled or ii) 
the assembly factors of the different respiratory enzymes are shared [Porras and Bai, 2015; 
Vartak et al., 2013]. Certainly, it has been demonstrated that cardiolipin, a phospholipid 
which is almost exclusively found in the inner mitochondrial membranes, is necessary for 
electron transfer between CI and CIII and essential for the formation of the CIII2+IV SC 
[Bazán et al., 2013]. True chaperones of SC assembly are two proteins named Rcf-1 and 
Rcf-2. In yeast these proteins were shown to directly interact with CIV and indirectly with 
CIII. In addition, this latter interaction is necessary for the formation of the CIII2+IV SC. 
The mammalian orthologs of these proteins are the hypoxia-induced genes HIG1A and 
HIG2A. Knockdown of HIG1A has no effect on the level of SCs, whereas loss of HIG2A 
reduced the levels of all SCs containing CIV without reduction in the amount of free CIV 
[Chen et al., 2012; Vukotic et al., 2012]. Another protein considered a SC assembly factor is 
Cox7a2l (SCAF1; SC assembly factor 1) which was shown to be present in I+III+IV and 
III+IV SCs, but not in free complexes. Mutations on SCAF1 does not allow the assembly 
of CIV in SCs [Lapuente-Brun et al., 2013]. Finally, the co-chaperone MCJ/DnaJC15 was 
demonstrated to act as a negative regulator of SC assembly. This protein, localized in the 
inner membrane, binds CI and inhibits the formation of SCs [Hatle et al., 2013].  
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1.6 Mitochondrial diseases 
The mtDNA is localized in proximity to the inner membrane, near the respiratory 
complexes where the ROS are routinely produced. As discussed in paragraph 1.1.3, 
differently of nuclear DNA, mtDNA is not associated to histones whose role is also to 
protect DNA, thus mtDNA is much more exposed to oxidative damage and more 
vulnerable to insults. Although many antioxidant systems and DNA repair enzymes exist in 
mitochondria, it is believed that they are not sufficient to prevent DNA mutation caused by 
oxidative damage [Cha et al., 2015]. In addition to oxidative damage exposure, the 
inefficiency of DNA maintenance and replication systems can generate errors, thus 
inducing mutations [Keogh and Chinnery, 2015]. Owing to this, the mitochondrial genome 
has a very high mutation rate, 10- to 17-fold higher than that of the nuclear DNA [Tuppen 
et al., 2010]. The mtDNA alterations can be neutral or pathogenic. Usually, the neutral 
mutations are polymorphisms which do not alter proteins and are termed haplogroups. The 
pathogenic mutations (either point mutations or DNA arrangements, such as deletion, 
duplications or inversions) are associated with disorders termed mitochondrial diseases 
[Keogh and Chinnery, 2015]. 
Mitochondrial diseases are a clinically heterogeneous group of disorders that arise 
as a result of dysfunctions of the respiratory chain [Cha et al., 2015]. The first genetic defect 
in the human mitochondrial genome were described in 1988 [Holt et al., 1988; Wallace et al., 
1988]. Mitochondrial disorders can be caused by mutation in both nuclear DNA genes 
encoding mitochondrial proteins and in mtDNA genes, encoding protein subunits of 
OXPHOS complexes and the structural RNAs for their expression. Thus, these 
pathologies mainly affect tissues with high energy demands. Mitochondrial disorders can 
affect either a single organ or involve multiple organ systems, with prominent neurologic 
and myopathic features. Mitochondrial diseases can arise throughout each decade of life 
[Lightowlers et al., 2015]. 
Many individuals with mutations of mtDNA often display a cluster of clinical 
features that fall into a discrete clinical syndrome. However, considerable clinical variability 
exists and many individuals do not fit neatly into one particular category. As introduced in 
1.1.3, the presence of multiple DNA copies causes the homoplasmy and heteroplasmy 
conditions. These features are important to explain the several phenotypes of 
mitochondrial disorders. Indeed, the most severe pathogenic mutations associated with 
mitochondrial disorders are in heteroplasmic condition. The ratio of wild-type to mutant 
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mtDNA determines the onset of clinical symptoms. A minimum critical proportion of 
mutated mtDNA is necessary before biochemical defects and tissue dysfunction become 
apparent (threshold effect). The threshold level varies for each mutation and differs 
amongst tissues. Typically, the threshold value is in the range of 60%–90% mutant to wild-
type mtDNA [D’Aurelio et al., 2006; Keogh and Chinnery, 2015; Tuppen et al., 2010]. 
Establishing the exact prevalence of mitochondrial diseases is difficult because of 
the clinical and genetic heterogeneity, a suggested value in children is 6.2/100,000 [Skladal 
et al., 2003] [Skladal et al., 2003]. Adult mitochondrial diseases, including pathogenic 
mutations of both genomes, is estimated to be approximately 1 in 4300 [Gorman et al., 
2015]. Treating patients with established mitochondrial disease remains a major challenge, 
at present therapy is limited to either preventing or treating the complications of the 
diseases [Lightowlers et al., 2015]. 
 
1.6.1 Mitochondrial diseases associated with CIII 
The deficiencies associated with mutations of CIII are the least frequently 
diagnosed because of the lack of the specific hallmarks. As for all mitochondrial disease, 
also the CIII deficiencies show different phenotypes. The majority of patients present 
exercise intolerance, lactic acidosis and involvement of skeletal muscles [Fernández-Vizarra 
and Zeviani, 2015]. The best known CIII-linked deficiencies are associated with three 
genes: MT-CYB encoding cytochrome b [Andreu et al., 1999], the nuclear genes BCS1L [de 
Lonlay et al., 2001], involved in the assembly of CIII, and UQCRB [Haut et al., 2003], a 
subunit of CIII involved in electron transport. In the last years, mutations in seven more 
CIII-disease nuclear genes have been identified. UQCRQ [Barel et al., 2008], UQCRC2 
[Miyake et al., 2013] and CYC1 [Gaignard et al., 2013], encoding structural subunits of CIII, 
and TTC19 [Ghezzi et al., 2011], LYRM7 [Invernizzi et al., 2013], UQCC2 [Tucker et al., 
2013] and UQCC3 [Wanschers et al., 2014] which are assembly factor. All mutations in 
nuclear genes follow an autosomal recessive pattern of inheritance [Fernández-Vizarra and 
Zeviani, 2015]. 
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Figure 1.19 Complex III deficiency in humans [from Bénit et al., 2009].  
 
1.6.1.1 Pathogenic mutations in cytochrome b  
The MTCYB gene exhibits a high level of variance. Although most variations are 
silent, those affecting critical regions involved in catalytic activity can prove very deleterious 
[Bénit et al., 2009]. Usually the MTCYB mutations are associated with mitochondrial 
diseases causing myopathy and exercise intolerance; however, some mutations have been 
described also in patients with specific cancers [Dasgupta et al., 2008; Polyak et al., 1998]. 
Since 1970, many clinical cases of patients affected by muscle weakness, 
progressive ataxia, dementia, lactic acidosis and nervous system disorder, have been 
described, where biochemical studies performed on muscle biopsies revealed a defect on 
CIII and a lower content in cytochrome b [Birch-Machin et al., 1989; Darley-Usmar et al., 
1983; Hayes et al., 1984; Morgan-Hughes et al., 1982; Spiro et al., 1970]. Given that 
complete sequencing of mtDNA was not routinely evaluated, most clinical cases were not 
analyzed at molecular level until 1990s. Since then, many mutations in MT-CYB causing 
CIII-linked disorders have been reported, including frame-shift and termination mutations, 
deletions, and missense mutations affecting amino acids in the trans-membrane portion of 
the protein [Meunier et al., 2013]. The most recurrent MTCYB mutations are missense 
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mutations caused by AG transition as a consequence of oxidative damage. Most of them 
are heteroplasmic, only one was reported as homoplasmic [Fragaki et al., 2009]. Usually, 
they are sporadic and often detected in skeletal muscle tissues [Fernández-Vizarra and 
Zeviani, 2015].  
The MTCYB missense mutation m.15579A>G, which substitutes Tyr at position 
278 with Cys (p.278Y>C) was identified in a patient suffering severe exercise intolerance 
and multisystem manifestations (deafness, retinitis pigmentosa, cataract, cognitive 
impairment, growth retardation and epilepsy) [Wibrand et al., 2001]. This mutation caused a 
dramatic decrease of CIII enzymatic activity and was present in heteroplasmy (88%) in the 
patient’s muscle. Tyr278 is a highly conserved amino acid, indicating an essential role in the 
enzymatic function and explaining the severe symptoms of the patient. Several previous 
studies in bacterial models (Rhodobacter spheroides and Rhodobacter capsulatus) where the 
molecular mechanisms involved in CIII electron transfer and catalytic activity have been 
deeply investigated, have highlighted that specific amino acids at the QO site provided 
protective mechanisms against CIII oxidative damage [Crofts et al., 2000; Mather et al., 
2005]. In particular, the conserved Tyr residue at position 302 of R. Capsulatus cytochrome 
b, corresponding to human Tyr278, was important, as demonstrated by its substitution with 
other amino acids. In particular Y302C substitution led to chemical cross-linking of 
cytochrome b to the Fe/S subunit, rendering the bacterial enzyme inactive and sensitive to 
oxidative disintegration of its catalytic [2Fe/2S] cluster [Lee et al., 2011]. 
Another MTCYB mutation has been recently identified in a female patient 
suffering a multisystem disease characterized by sensorineural deafness, cataracts, retinal 
pigmentary dystrophy, dysphagia, postural and gait instability and myopathy with 
prominent exercise intolerance. The patient was treated at the IRCC Istituto delle Scienze 
Neurologiche, and DiBINEM, University of Bologna, by Prof. Valerio Carelli. Sequencing 
of entire mtDNA revealed a microdeletion of 18 bps at position 15649-15666, causing the 
loss of six amino acids (Ile-Leu-Ala-Met-Ile-Pro) in the protein, but leaving the remaining 
of the MTCYB sequence in frame. The percentage of mutant mDNA was very different in 
the proband's tissues: close to 50% in muscle and fibroblasts, at a much lower level in 
urinary epithelium, and not detectable in blood [Carossa et al., 2014].  
The detailed analysis of the biochemical alterations associated with MTCYB 
m.15579A>G missense mutation and 18 bps long microdeletion m.15649-15666 are the 
subjects of this thesis. 
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Figure 1.20 Schematic representation of cytochrome b structure, where mutations associated with human 
diseases are indicated. Most of the trans-membrane domains (A–H) are free from mutations. The red squares 
highlight the two pathogenic mutations whose effect have been analyzed in this study [modified from Bénit et al., 
2009]. 
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Aims 
Complex III is the central component of the respiratory chain. In eukaryotes only 
one of the 11 subunits, cytochrome b, is encoded by the mtDNA. Cytochrome b, together 
with the Fe/S cluster and cytochrome c1, constitutes the central catalytic core of CIII, 
which is conserved from bacteria to mammals. Despite the cytochrome b is highly 
conserved during evolution, many polymorphic variants are found in the MTCYB gene 
sequence. Although most of the variants are silent, those affecting regions crucial for the 
catalytic activity have proved pathogenic. These mutations, rather rare in comparison with 
others hitting the mtDNA, are most probably all somatic events detected in skeletal muscle 
in heteroplasmy, expressing clinically mainly as exercise intolerance and fatigue. The most 
recurrent mutations are missense mutations caused by AG transition as a consequence of 
oxidative damage. MTCYB mutations can cause different effects on CIII, impairing the 
enzymatic activity alone or also compromising its assembly. Moreover, given the strict 
interdependence of CI and CIII, these mutations can indirectly perturb also the activity and 
assembly of CI. 
The main goal of the present study has been to get detailed information on the 
kinetics and structural characteristics of CIII and of the CIII containing supercomplexes in 
cells bearing two different MTCYB pathogenic mutations. The first one is a missense 
mutation causing the substitution of a highly conserved tyrosine with a cysteine at position 
278 (m.15579A>G; p.278Y>C). Tyr278 is close the QO site, where QH2 oxidation occurs, 
and it is part of the interaction domain of cytochrome b with the Fe/S protein. The 
p.278Y>C mutation was identified in a female patient with severe exercise intolerance and 
multisystem manifestations. The second mutation is a novel microdeletion 18 bps long 
causing the loss of six aminoacids (Ile-Leu-Ala-Met-Ile-Pro) from position 300 to 305 in 
the sixth transmembrane helix of the protein, but leaving the remaining of the MTCYB 
coding region in frame (Δ15649-15666; ΔI300-P305). ΔI300-P305 was identified in a 
female patient suffering a severe multisystem disease.  
Given that MTCYB mutations are rare, it has been a great opportunity to acquire 
fibroblasts derived from these patients. The biochemical analysis has been carried out 
taking advantage of a cell model specifically developed to 
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investigate the mtDNA mutations, the cybrid cell model, that can be generated by fusion of 
the enucleated patient’s fibroblasts with osteosarcoma cells devoid of their own mtDNA 
(Rho0 cells). 
By using a combination of different spectrophotometric assays, the energetic 
efficiency of cells bearing the two MTCYB mutations has been evaluated, determining their 
viability after a metabolic stress, the redox activity of complexes and supercomplexes, along 
with their rate of mitochondrial ATP synthesis. Moreover, the pattern of respiratory 
complexes and supercomplexes has been investigated following their separation by gel 
electrophoresis under native conditions in the presence of different mild detergents.  
Our final aim was to shed light on the mechanisms through which complexes 
stability and supercomplexes organization can be modified by the presence of defective 
cytochrome b. This issue is important because alterations of the supramolecular 
organization of respiratory complexes have been suggested to have profound effects on the 
efficiency of electron transport and, even more relevant, on superoxide generation and 
consequent oxidative damage. Furthermore, elucidation of these mechanisms might be a 
first step toward development of more focused therapeutic strategies for treatment of these 
patients. 
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Experimental Procedures 
3.1 Cell Lines and Culture Conditions 
To study the effect of the two MTCYB mutations, trans-mitochondrial 
cytoplasmic hybrids (cybrids) were established from patient fibroblasts obtained, after 
informed consent, from skin biopsies as previously reported [King and Attardi, 1996]. 
Patient fibroblasts, bearing the mutation of interest, were enucleated by treatment with 
cytochalasin B followed by centrifugation, to obtain cytoplasts, which are cells lacking 
nuclei but containing mitochondria, and used to repopulate rho-0 cells, which are 
osteosarcoma (143B.TK-)-derived cells depleted of their own mtDNA. To obtain rho-0 
cells, cells deficient in thymidine kinase activity (TK−), were exposed to ethidium bromide 
(EtBr), which is an inhibitor of mtDNA replication. The rho0 cells, which are auxotrophic 
for uridine and pyruvate (U−, P−), are repopulated by forming hybrids with cytoplasts from 
a patient cell line. After fusion, cells are plated in media containing bromodeoxyuridine 
(+BrdU) and lacking either pyruvate or uridine (−U or −P), which permits only the growth 
of ρ0 cells that have fused with cytoplasts containing functional mitochondria (TK+ donor 
cells cannot grow in the presence of BrdU). If heteroplasmic cells are used as donors, it is 
possible to isolate cybrid clones that harbour varying proportions of mutated mtDNAs, 
ranging from 0% mutant (that is, 100% wild type) to 100% mutant (that is, 0% wild type). 
Both the parental rho-0 line and homoplasmic cybrid lines harbouring nonsense- or 
frameshift-mutated mtDNAs must be grown in media supplemented with uridine (+U; 
~200 μM) and pyruvate (+P; ~1 mM) (Figure 3.1) [King and Attardi, 1996; Schon et al., 
2012]. 
The p.278Y>C patient fibroblasts were heteroplasmic (88%) for the mutation, as 
well as the ΔI300-P305 patient fibroblasts (50%). From the cybridization procedure, several 
syngeneic clones were obtained; homoplasmic wild-type clones (100% wild-type mtDNA) 
and homopasmic mutated clones (100% of mutated mtDNA) were selected. For the 
p.278Y>C mutation several heteroplasmic clones were obtained (58, 78, 96% of mutation 
load). For the ΔI300-P305 microdeletion, only one clone 80% heteroplasmic was obtained. 
Experimental Procedures 
46 
 
 
 
Figure 3.1 Schematic representation of cybrids construction. The heteroplasmy of p.278Y>C and ΔI300-
P305 patient fibroblasts are indicated [modified from Schon et al., 2012]. 
 
Patient fibroblasts and wild-type clones were grown in DMEM with 25 mM 
Glucose (DMEM-HighGlucose) supplemented with 10% FBS, 2 mM L-Glutamine, 100 
units/mL Penicillin and 100 μg/mL Streptomycin (all of components were from GIBCO). 
Mutant cybrids were grown in the same medium supplemented with 50 µg/mL Uridine. 
Uridine is used in cybrids carrying severe impairment of respiratory chain and in particular 
for severe mutations in MTCYB in order to provide an alternative pathway for pyrimidine 
synthesis, since the activity of enzyme dihydroorotate dehydrogenase is dependent on 
quinol oxidation [Evans and Guy, 2004; King and Attardi, 1996]. Cells were grown in an 
incubator with a humidified atmosphere of 5% CO2 at 37°C.  
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In some experiments, cells were incubated with a glucose-free DMEM (DMEM-
Galactose) supplemented with 10% FBS, 5 mM Galactose, 5 mM Sodium Pyruvate, 2 mM 
L-Glutamine, 100 units/mL Penicillin and 100 μg/mL Streptomycin (all components were 
from GIBCO). 
 
3.2 Heteroplasmy Evaluation 
Genomic DNA was extracted from wild-type, homoplasmic and heteroplasmic 
cybrid clones using NucleoSpin®Tissue Kit. To amplify the MT-CYTB, polymerase chain 
reaction (PCR) was performed using 5 ng of the template DNA, 1U of Taq Gold DNA 
Polymerase (Applied Biosystems), Reaction Buffer, 2.5 mM MgCl2, 200 μM Nucleotide 
Mix 10 nM (Roche), 400 pM of primers forward and reverse (see Table 3.1) in a final 
volume of 30 μl. Thermocycler was set as shown in Table 3.2. PCR products were first 
controlled on 2% agarose gel and then eluted in a denaturing high performance liquid 
chromatography (dHPLC) using a column for ion exchange in reverse phase 
chromatography that specifically allows separation of nucleic acids. The ion exchange is 
provided by trymethil-ammonium acetate (TEAA) which binds both DNA, thanks to its 
positive charges, and the column with its hydrophobic portion. Analysis was performed at 
the non-denaturing temperature of 58.7°C for p.278Y>C and 50°C for ΔI300-P305. 
Difference in the length results in different elution times of PCR products, that finally 
results in different elution peak. We used a protocol already tested in characterization of 
heteroplasmy level of another mtDNA mutant [Kurelac et al., 2012]. 
 
3.3 Mitochondria isolation from cybrid cells 
Crude mitochondria were obtained by 15x106 cybrids. Cells were suspended in 
cold isolation buffer containing 200 mM D-Mannitol, 70 mM Sucrose, 1 mM EGTA, 10 
mM HEPES, pH 7.6, with protease inhibitor cocktail (Roche) and mechanically 
homogenized with 50 strokes using a glass-teflon potter in melting ice. Unbroken cells and 
nuclei were centrifuged at 3000 rpm for 10’ at 4°C, and the supernatant, containing 
mitochondria, was centrifuged at 13000 rpm for 20’ at 4°C. The mitochondrial pellet was 
suspended with cold isolation buffer and stored at -80°C. Protein content was quantified 
according to Bradford [Bradford, 1976]. 
Experimental Procedures 
48 
 
Membrane fractions enriched of mitochondrial proteins (mitoplasts) were isolated 
from cell pellets (10x106 cells) using digitonin (final concentration 50 µg/mL). Digitonin 
binds to membrane cholesterol, destabilizing and solubilizing the cellular membranes. The 
inner membrane, unlike the outer membrane, is almost devoid of cholesterol, therefore 
digitonin solubilizes cellular membranes, except the inner membrane, which remaining 
intact can be isolated. Briefly, cells were centrifuged and pellet suspended at a 
concentration of 10x106 cells/mL with cold PBS (154 mM NaCl, 1 mM KH2PO4, 3 mM 
Na2HPO4 ), and after addition of digitonin, incubated on ice for 1’. Cold PBS was then 
added to 2.5- fold dilute the suspension volume, thus interrupting cell permeabilization. 
The digitonin treatment was repeated until at least 90% of the cells were permeabilized, as 
detected at the microscope by Trypan blue cell permeabilization. Cells were then 
centrifuged at 13000 rpm for 15’ at 4°C and the pellet was stored at -80°C. Protein content 
was quantified according to Bradford [Bradford, 1976]. 
 
3.4 Cellular lysates  
1x106 cells were seeded into 10 cm dish in DMEM-high glucose and after 48h, 
pelleted and washed in PBS. The pellet was suspended in 150-200 µl lysis buffer (1% 
Triton X-100, 0.5 mM EDTA, 0.6 mM PMSF, pH 7.4) and protease inhibitor cocktail 
(Roche). The lysate was incubated on ice for 15’, frozen and thawed twice, sonicated in a 
water-bath for 1’ and centrifuged at 13000 rpm for 15’ at 4°C. The supernatant was then 
collected and protein content was assessed according to Bradford [Bradford, 1976]. 
 
3.5 Solubilization of mitochondrial membranes 
Mitoplasts or crude mitochondria were isolated from cultured cybrids as 
previously described. Mitochondrial proteins were solubilized by adding 2% n-Dodecyl β-
D-maltoside (DDM), left on ice for 10’ and centrifuged at 13000 rpm for 15’ at 4°C. 
Supernatant was kept and protein content was determined. 
 
3.6 Cell viability assay 
Cell viability was determined by using the colorimetric Sulforhodamine B (SRB) 
assay. The assay is based on the ability of the SRB dye to bind electrostatically to protein 
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basic amino acid residues, in a pH dependent manner [Skehan et al., 1990]. Cells 
(30.000/well) were seeded into 4- or 24-well plates. After 24h, cells were washed twice with 
PBS and incubated with different media for the times indicated in legends of figures. At the 
end of incubation, the medium was removed, fresh medium was added together with 10% 
trichloro-acetic acid, and cells were kept for 1h at 4°C, then washed five times with H2O 
and dried for 1h at room temperature. Cells were stained with 0.4% SRB in 1% acetic acid. 
Unbound dye was removed with four washes in 1% acetic acid. Bound dye was solubilized 
by addition of 10 mM Tris pH 10, after mild shaking for 10’. Absorbance was measured at 
564 nm by using a micro-plate reader [VICTOR3 Multilabel Plate Counter (PerkinElmer 
Life and Analytical Sciences, Zaventem Belgium)]. 
 
3.7 Mitochondrial ATP synthesis  
Mitochondrial ATP synthesis was determined in digitonin-permeabilized cybrids, 
using a luciferin/luciferase assay (Sigma-Aldrich) and a Bio Orbit 1250 Luminometer, as 
previously described [Manfredi et al., 2002], with minor modifications [Giorgio et al., 2012]. 
Briefly, after trypsinization, cells were suspended (10x106/mL) in Buffer A (150 
mM KCl, 25 mM Tris-HCl, 2 mM EDTA, 10 mM KH2PO4, 0.1 mM MgCl2, pH 7.4) and 
one aliquot was taken to measure protein content. Then, cells were permeabilized with 50 
μg/mL digitonin for 1’ at room temperature in slight agitation. The action of digitonin was 
blocked by 2.5 fold dilution with Buffer B (Buffer A plus 0.1% BSA). After 
permeabilization, cells were centrifuged to eliminate digitonin and suspended again in 
Buffer B at the initial concentration and used to measure ATP synthesis and citrate 
synthase (CS, see below). 
Aliquots of digitonin-permeabilized cells were incubated with the 
luciferin/luciferase buffer in the presence of substrates of different complexes: 1 mM 
Pyruvate and 1 mM Malate for CI, and 5 mM Succinate and 5 μM Rotenone for CII. The 
reaction was started by addition of 100 μM ADP. At the end, 5 μM Oligomycin and 10 μM 
ATP were added, to inhibit the ATP synthase activity and as an internal standard, 
respectively. The rate of ATP synthesis was normalized to protein content, and expressed 
as a ratio of CS activity and as percentage of the activity of untreated cells. 
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3.8 Citrate synthase activity 
The activity of CS was evaluated in mitochondria suspended in a buffer 
containing 125 mM Tris-HCl, 0.1% Triton X-100, 100 μM DTNB (ε= 13.6 mM-1), 300 
μM Acetyl-CoA, pH 8. The reaction was started by addition of 500 μM Oxaloacetate 
[Trounce et al., 1996] and measured at 412 nm at 30°C with UV-Vis spectrophotometer 
(V550 Jasco).  
 
3.9 Respiratory complexes activities  
Crude mitochondria, isolated as described in paragraph 3.3, were used to measure 
redox activities with a UV-Vis spectrophotometer (V550 Jasco). 
For CI and CII activity, spectrophotometric assay was performed at 600nm 
wavelength, at 37°C and under continuous stirring, by following the 2,6-
Dichlorophenolindophenol (DCIP) reduction. Kinetic was calculated using the DCIP 
molar extinction coefficient (19.1 mM-1cm-1). The CIII and CIV activities and combined 
CI+III and CII+III activities were analyzed with a dual-wavelength spectrophotometer 
(540 nm-550 nm), at 37 °C and under stirring, following the reduction or oxidation of 
cytochrome c (molar extinction coefficient 19.1 mM-1cm-1). 
25 µg of crude mitochondria were used in each assay. The specific activity was 
measured after subtraction of non-specific activity conducted in a separate assay, adding 
the specific complex inhibitors at the beginning of the reaction (CI: 1 µM Rotenone; CII: 5 
mM Malonate; CIII: 1 µM Antimycin A; CIV: 300 µM KCN; CI+III: 1 µM Rotenone and 
1 µM Antimycin A; CII+III: 5 mM Malonate and 1 µM Antimycin A) [Carossa et al., 2014; 
Ghelli et al., 2013]. For details about reaction components see Table 3.3. 
 
3.10 Determination of GSH/GSSG content 
GSH and GSSG concentrations of cybrids incubated in DMEM and DMEM-
Galactose were measured enzymatically, as described in [Anderson, 1985; Floreani et al., 
1997]. Briefly, the assay is based on the determination of a chromophoric product, 2-nitro-
5-thiobenzoic acid, resulting from the reaction of 5,5′-dithiobis-(2-nitrobenzoic acid) with 
GSH. In this reaction, GSH is oxidized to GSSG, which is then reconverted into GSH in 
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the presence of glutathione reductase and NADPH. The rate of 2-nitro-5-thiobenzoic acid 
formation is measured spectrophotometrically at 412 nm. 
Cells (~10x106) were washed once with PBS. After collecting an aliquot for 
protein content determination, cells were treated with 6% metaphosphoric acid.. After 10’, 
the acid extract was collected, centrifuged for 5’ at 16000 g at 4°C, and processed. For total 
GSH determination, the acid extract was diluted (1:6) in 6% metaphosphoric acid; an 
aliquot was added to 0.75 mL of KPi/EDTA buffer (0.1 M KPi, 5 mM EDTA, pH 7.4), 0.7 
mM 5,5′-dithiobis-(2-nitrobenzoic acid) and 0.5 mM NADPH. After 3’ incubation at 25°C, 
the reaction was started by addition of 2U glutathione reductase (type III; Sigma; from 
yeast). Product formation was continuously recorded at 412 nm by using a micro-plate 
reader [VICTOR3 Multilabel Plate Counter (PerkinElmer Life and Analytical Sciences, 
Zaventem Belgium)]. The total amount of GSH in the samples was determined from a 
calibration line obtained by plotting known amounts of GSH against the rate of absorbance 
change at 412. GSH standards were prepared daily in 6% metaphosphoric acid and diluted 
in KPi/EDTA buffer. For GSSG measurement, immediately after preparation, the 
supernatant of acid extract was treated for derivatization with 2-vinylpyridine at room 
temperature for 60’. In a typical experiment, 0.15 mL supernatant was treated with 3 µL 
undiluted 2-vinylpyridine. Then 9 µL triethanolamine was added. The mixture was 
vigorously mixed, and the pH was checked; it was generally between 6 and 7. After 60’, 0.1 
mL aliquots of the samples were assayed by the procedure described above for total GSH 
measurement. The amount of GSSG was quantified from a standard curve obtained by 
plotting known amounts of GSSG against the rate of absorbance change. GSH present in 
the samples was calculated as the difference between total glutathione and GSSG 
concentrations. 
 
3.11 Hydrogen peroxide production analysis 
 H2O2 production was determined using 2',7'-dichlorodihydrofluorescein diacetate 
(H2DCFDA) as previously described [Porcelli et al., 2010]. H2DCFDA is a cell-permeable 
non-fluorescent probe converted to highly fluorescent 2',7'-dichlorofluorescein (DCF) after 
oxidation by hydrogen peroxide. 
Briefly, 40.000 cells/well were seeded into 24-well plates. After 24h, cells were 
incubated for 30’ in DMEM without red phenol to avoid interference with H2DCFDA 
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fluorescence (DMEM-RedPhe: 25 mM Glucose, 25 mM HEPES pH 7.4, 5 mM Sodium 
Pyruvate and 2 mM/L L-Glutamine) and then 2μM H2DCFDA was added. After 30’, the 
probe was removed, adding fresh medium, and fluorescence was determined (λex= 492–
495nm; λem= 517–527nm) using a multilabel plate reader [VICTOR
3 and Analytical 
Sciences, Zaventem Belgium)]. At the end of the experiment, the number of cells present 
in each well was measured by using the SRB assay (see 3.6 paragraph). 
 
3.12 SDS-PAGE 
50 µg of cellular lysates or 100 µg of mitochondrial proteins were diluted in SDS 
Loading Buffer (60 mM Tris-HCl pH 6.8, 2% SDS, 2.5% β-mercaptoethanol, 0.025% 
Bromophenol Blue, 5% Glycerol) incubated for 5’ at 100°C and loaded on 10% 
polyacrylamide gels (see Table 3.4). Electrophoresis was performed in SDS-Running Buffer 
(25 mM Tris, 192 mM Glycine, 3.5 mM SDS, pH ~8.3). Initial voltage was 30V and after 
~1h was shifted to 100V. 
 
3.13 Respiratory complexes analysis by Blue Native- and Clear Native-
PAGE 
Fully assembled respiratory complexes were separated through Blue Native-
PAGE (BN-PAGE) or Clear Native-PAGE (CN-PAGE) [Wittig et al., 2007]. Mitoplasts 
were suspended in mitochondrial buffer (750 mM 6-Aminocaproic Acid, 50 mM BisTris, 
pH 7.0), quantified and solubilized by adding DDM (2.5 mg/mg protein). Afterwards, 
samples were incubated on ice for 10’ and then centrifuged at 13000 rpm for 15’ at 4°C. 
The supernatant containing the mitochondrial proteins was then collected and protein 
content quantified again.  
BN-Sample Buffer (0.5% Serva G Blue in 75 mM 6-Aminocaproic Acid, 5 mM 
BisTris, 0.05 mM EDTA, pH 7), or CN-Sample Buffer (0.01% Red Ponceaux in 5% 
Glycerol) was added to 100 µg of solubilized mitoplasts and loaded onto a native gel 
constituted by a gradient of polyacrylamide from 4% to 12%, casted with a gradient mixer 
and a peristaltic pump (Delta-Pump) (see Table 3.5). For BN-Page it was used Anode 
Buffer (25 mM Imidazole, pH 7) and Cathode Buffer A (50 mM Tricine, 7.5 mM 
Imidazole, 0.02% Serva G Blue, pH 7), which was halfway replaced with Cathode Buffer B 
(50 mM Tricine, 7.5 mM Imidazole, pH 7). For CN-Page it was used Anode Buffer and 
Experimental Procedures 
53 
 
CN-Cathode Buffer (50 mM Tricine, 7.5 mM Imidazole, 0.02% DDM, 0.05% NaDOC, 
pH 7). The electrophoresis was run at 80V. 
 
3.14 Supercomplexes analysis by BN-PAGE 
Mitoplasts were suspended in cold PBS and protein content quantified. 
Mitochondrial suspension was centrifuged at 13000 for 10’ at 4°C, suspended (5 mg 
protein/ml) in supercomplex buffer [150 mM K-Acetate, 30 mM HEPES pH 7.4, 10% 
(w/v) Glycerol, 1% (w/v) Digitonin and 1 mM PMSF] and incubated for 30’ on ice. 
Suspension was centrifuged at 3000 rpm for 2’ at 4°C, then the supernatant collected and 
Sample Buffer added (0.25% Serva Blue G in 37.5 mM 6-Aminocaproic Acid). Native gel 
was prepared as described (see paragraph 3.13 and Table 3.5), with a gradient of 
polyacrylamide from 3% to 12%. Electrophoresis was run at 80V and performed with 
Anode Buffer and Cathode Buffer A, which was halfway replaced by the Cathode Buffer B. 
 
3.15 Complex I In-Gel activity 
After electrophoresis, gels were submerged for 15’ at room temperature, in the 
dark, in a solution containing 2 mM Tris-HCl, 0.5% 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and 0.02% NADH [Wittig et al., 2007]. Complexes 
and Supercomplexes containing CI appeared as black bands due to reduction of MTT to 
tetrazolium salts by NADH oxidation through CI. 
 
3.16 Two dimensional blue native/SDS-PAGE 
Lanes, previously separated by BN-PAGE gel, were cut out from the first 
dimension gel and incubated 90’ with a dissociating solution (1% SDS and 0.1% β-
mercaptoethanol). Electrophoresis was then performed onto 10% polyacrylamide gel (see 
Table 3.6) by using Cathode (100 mM Tris-HCl, 100 mM Tricine, 0.1% SDS, pH 8.2) and 
Anode (200 mM Tris-HCl pH 8.9). Initial voltage was 30V, after ~1h was shifted to 100V. 
3.17 Super-supercomplex band SDS-PAGE 
Supercomplexes were separated as described in the 3.14. paragraph. At the end of 
the electrophoresis, the gel was stained overnight in Colloidal Coomassie Blue (10% 
Ammonium Sulfate, 0.1% Coomassie G-250, 3% Ortho-Phosphoric Acid, 20% Ethanol, 
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H2O up to the final volume) and then de-stained with H2O until the bands were clearly 
visible. The bands at high molecular weights corresponding to the SSC were excided from 
the gel and separated on a 12% polyacrylamide gel (see Table 3.7). Electrophoresis was 
performed in Cathode (100 mM Tris-HCl, 100 mM Tricine, 0.1% SDS, pH 8.2) and Anode 
(200 mM Tris-HCl pH 8.9). Initial voltage was 30V, after ~1h was shifted to 100V. 
 
3.18 Western Blotting 
Proteins separated on acrylamide gels were transferred on nitrocellulose filters for 
further analysis with antibodies. Gel was incubated for 5’ in Western Transfer Buffer (25 
mM Tris, 192 mM Glycine, 0.02% SDS, 20% Methanol, pH ~8.3) together with the 
Whatman papers and nitrocellulose filters (thickness 0.2 mm, 0.22 mm porosity, BioRad). 
Sandwiches were composed with two sponges, two Whatman papers, gel and nitrocellulose 
filter. Full wet transfer was performed at 100V for 1h at 4°C in Western Transfer Buffer. 
After transfer, unspecific sites of nitrocellulose were saturated with 5% fat-free 
milk in Tris-buffered saline (137 mM NaCl, 20 mM Tris-HCl, pH 7.6) with 0.05% Tween 
(TBS-T) for 1h at room temperature using a rotatory shaking. Nitrocellulose incubation 
with specific primary antibodies diluted in 5% fat-free milk in TBS-T was carried out 
overnight at 4°C, or alternatively for 2h at room temperature. The following antibodies 
were used: Complex I anti-NDUFA9 (Invitrogen, diluted 1:1000) and anti-NDUFS3 
(Abcam, diluted 1:2000) antibodies; Complex II anti-SDHA antibody (Invitrogen, diluted 
1:10000); Complex III anti-Core2 antibody (Invitrogen, diluted 1:1000); Complex IV anti-
CoxIV and Cox5A antibodies (Abcam; diluted 1:1000); anti-Actin antibody (Santa Cruz, 
diluted 1:500); anti-Catalase antibody (Sigma Aldrich, diluted 1:2000); anti-MnSOD 
antibody (Upstate, diluted 1:2000); anti-P-Tyr antibody (Sigma Aldrich, diluted 1:2000); 
anti-Peroxiredoxin3 antibody (ABFrontiers, diluted 1:2000); anti-VDAC antibody (Abcam, 
diluted 1:1000). 
After incubation, nitrocellulose membrane was washed 3 times for 10’ with TBS-
T and subsequently incubated for 1h with the proper peroxidase-conjugated secondary 
antibody (anti-mouse or anti-rabbit, Jackson Laboratories, diluted 1:2000 in 5% fat-free 
milk in TBS-T). After 3 washes in TBS-T, nitrocellulose was soaked for 1’ in ECL Western 
Blot Solution (0.015% H2O2, 68 μM Coumaric Acid and 1.25 mM Luminol). The emitted 
light was detected by using the Gel Logic 1500 Imaging System (Kodak). 
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3.19 In Vitro mitochondrial translation assay 
In vitro mitochondrial translation assay was performed in collaboration of Dott. 
Marina Roberti – Università di Bari. Cells (80% confluent) were washed twice and 
incubated with methionine/cysteine-free DMEM for 15’ at 37°C at 5% CO2. Incubation 
medium was removed and replaced with mL of methionine-free DMEM supplemented 
with 5% dialyzed serum, 1 mM sodium pyruvate, 2 mM L-glutamine, 96 µg/mL cysteine 
and 100 µg/mL emetine dihydrochloride. Cells were incubated for 20’ at 37°C at 5% CO2 
before addition of 166 µCi/mL [35S]-methionine to the culture medium. Labelling was 
performed for 60’ at 37°C at 5% CO2, then cells were washed with ice-cold phosphate 
buffered saline (PBS) and harvested.. Cell pellet was suspended in PBS containing 0.1% 
DDM and 2 U/µL benzonase and incubated on ice for 30’. Then 1% SDS was added and 
protein quantification was performed using the DC protein assay (Biorad). Protein samples 
(30 µg) were separated on 10–20% pre-casted SDS-PAGE gels (Invitrogen). Gels were 
stained with Coomassie Brilliant Blue for 10’, destained for 1 hour and scanned. Gels were 
dried before exposure to a Phosphorimager screen. Radiolabelled proteins were analysed by 
using a Typhoon™ Phosphorimager system and an ImageQuant software (Molecular 
Dynamics, GE Healthcare). 
 
3.20 In silico dynamic simulation for I300-P305 mutation 
This analysis was performed in collaboration with the Prof. Alejandro 
Hockoeppler – Università di Bologna. 
PDB file of bovine mitochondrial CIII derived from the crystal structure obtained 
in 1998 was used to perform in silico analysis [Iwata et al., 1998]. Swiss PBD viewer software 
has been utilized to isolate subunits 6Å closer to the deleted residues (I300-P305) of 
cytochrome b subunit in a single monomer of the entire CIII. Cytochrome c1, Sub6, Sub7 
and Rieske were the subunits resulting from the operation described above. Residues I300-
P305 of cyt b were deleted simulating the effect of the patient’s microdeletion. Visual 
Molecular Dynamic software was used to run in vacuum for 10 ps the effect of the 
microdeletion on the selected subunits. 
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3.21 Statistics 
All experiments were repeated at least three times, and the results are presented as 
the mean ± SD, unless otherwise indicated. Statistical analysis was performed using the 
Student's t-test, with *P ≤ 0.05 or **P ≤ 0.01 as the level of significance. 
 
 
 
 
Table 3.1 The primer seuquences and the length PCR products for both of mutations are indicated. 
 
 
Table 3.2 The thermocycler settings for both of mutations. 
 
 
 
 
Mutation Sequence PCR Product
A15579G 5’-CCGAATGATATTTCCTATTCGTC-3’ Forward
p.278Y>C 5’-GGAGGATGGGGATTATTGCT-3’ Reverse
Δ15.649-15.666 5'-CAAACTAGGAGGCGTCCTTGCCCTATTACGA-3’ Forward 170 bp WT gene
ΔI300-P305 5'-ACTGGTTGTCCTCCGATTCAGG-3' Reverse 152 bp Mutated gene
114 bp
Table 3.1 Primers
Mutation Phase Temperature Time Cycles
Initial Denaturation Phase 94°C 5' 1
Denaturation 94°C 30''
56°C 
60°C
Extention 72°C 30''
Final Phase Lasting 72°C 7' 1
Initial Denaturation Phase 95°C 5' 1
Denaturation 95°C 30''
Annealing 55°C 30''
Extention 72°C 30''
Final Phase Lasting 72°C 7' 1
Table 3.2 Thermocycler settings
A15579G
25Annealing 30''
p.278Y>C
Δ15.649-15.666
30
ΔI300-P305
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Table 3.3 Reaction components for redox activity measurement of complexes and supercomplexes. 
 
 
 
 
 
50 mM KPi pH 7.8 50 mM KPi pH 7.8
3.5 mg/mL BSA 3.5 mg/mL BSA
25 µg crude mitochondria 1 mM EDTA
70 µM DUB 20 µM Cytochrome c  Reduced
60 µM DCIP (in 5 mM KPi pH 7.8) 1 µM Antimycin A
1 µM Antimycin A
Starter: 200 µM NADH Starter: 25 µg crude mitochondria
100 mM KPi pH 7.8 50 mM KPi pH 7.8
1 mg/mL BSA 3.5 mg/mL BSA
2 mM EDTA 300 µM KCN
25 µg crude mitochondria 25 µg crude mitochondria
200 µM ATP 20 µM Cytochrome c  Oxidized
50 µM DUB
80 µM DCIP Starter: 150 µM NADH
1 µM Antimycin A
1 µM Rotenone
300 µM KCN
Starter: 10 mM Succinate
50 mM KPi pH 7.8 50 mM KPi pH 7.8
3.5 mg/mL BSA 3.5 mg/mL BSA
300 µM KCN 300 µM KCN
20 µM Cytochrome c  Oxidized 2 mM EDTA
25 µg crude mitochondria 20 µM Cytochrome c  Oxidized
1 µM Rotenone 25 µg crude mitochondria
5 mM Malonate 1 µM Rotenone
Starter: 50 µM DBH2 Starter: 5 mM Succinate
Complex III Complex II+III
Table 3.3 Reaction components for Redox Activities measurement
Complex I Complex IV
Complex II Complex I+III
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Table 3.4 Composition of polyacrylamide gel for SDS-Page 
 
 
 
 
Table 3.5 Composition of polyacrylamide gel for BN/CN-Page. 
 
 
 
Table 3.6 Composition of polyacrylamide gel for 2D/SDS-Page. 
 
BAM 30%* mL 0.4 3.33
UGB** mL 0.61 -
LGB*** mL - 2.67
MilliQ mL 1.5 4
APS 10% µL 25 50
TEMED µL 10 20
*BAM 30%: acrylamide/bis-acrylamide 37:1
**UGB: 500 mM Tris-HCl, 14 mM SDS, pH 6.8
***LGB: 1.5 M Tris-HCl, 14 mM SDS, pH= 8.8
Table 3.4 SDS-PAGE gel components
Stacking Gel 5% Running Gel 10%
BAM 40%* mL 0.3 0.4 0.375 0.5 1.5
BN-GB3X** mL 1.33 1.33 1.67 1.67 1.67
Glycerol mL - - - - 0.5
MilliQ mL 2.37 2.27 3.29 2.83 1.33
APS 10% µL 80 80 25 25 15
Temed µL 8 8 2.5 2.5 1.5
**BN-GB3X: 75 mM Imidazole, 1.5 M 6-Aminocaproic Acid, pH 7
Table 3.5 BN/CN-PAGE gel components
Stacking Gel 4% Running Gel 3% Running Gel 4% Running Gel 12%
*BAM 40%: acrylamide/bis-acrylamide 19:1
Stacking Gel 3%
BAM 30%* mL 0.533 3.33
SDS-GB3X** mL 1.33 3.33
Glycerol 50% mL - 2.1
MilliQ mL 2.14 1.24
APS 10% µL 100 80
Temed µL 10 8
**SDS-GB3X: 3 M Tris-HCl, 0.3% SDS, pH 8.45
Table 3.6 2D BN/SDS-PAGE gel components
Stacking Gel 4% Running Gel 10%
*BAM 30%: acrylamide/bis-acrylamide 37:1
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Table 3.7 Composition of polyacrylamide gel for SSC-SDS-PAGE. 
BAM 30%* mL 0.533 4
SDS-GB3X** mL 1.33 3.33
Glycerol 80% mL - 1.3
MilliQ mL 2.14 1.4
APS 10% μL 100 80
Temed μL 10 8
**SDS-GB3X: 3 M Tris-HCl, 0.3% SDS, pH 8.45
Table 3.7 SSC-SDS-PAGE gel components
*BAM 30%: acrylamide/bis-acrylamide 37:1
Stacking Gel 4% Running Gel 12%
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Results 
In the present study, the biochemical profile of cells bearing the pathogenic 
MTCYB mutations p.278Y>C and ΔI300-P305 was investigated. The p.278Y>C mutation 
(m.15579A>G) was identified in a female patient with severe exercise intolerance and 
multisystem manifestations (deafness, retinitis pigmentosa, cataract, cognitive impairment, 
growth retardation and epilepsy), and it was present in patient’s skeletal muscle in 
heteroplasmy (88%). The mutation causes the substitution of a highly conserved tyrosine 
with a cysteine at position 278 (Figure 4.1B) [Wibrand et al., 2001]. The tyrosine is close the 
QO site, where QH2 oxidation occurs (Figure 4.1A). This residue is part of the docking 
niche of the iron-sulfur protein subunit of the enzyme and is H-bonded to the backbone of 
a cysteine residue of this subunit to correctly position its [2Fe-2S] cofactor at the QO site 
[Lee et al., 2011]. The role of this residue has been deeply studied in bacteria. In particular, 
it has been shown that the substitution of this conserved residue (Tyr302 in R. capsulatus) 
with a cysteine led to formation of a chemical cross-linking between cytochrome b and the 
Fe/S subunits, rendering the bacterial enzyme inactive and sensitive to oxidative 
disintegration of its catalytic [2Fe/2S] cluster [Lee et al., 2011].  
The ΔI300-P305 (Δ15649-15666) is a novel mutation identified in a female patient 
with a heteroplasmy close to 50% in muscle and fibroblasts. The patient suffered of a 
multisystem disease characterized by sensorineural deafness, cataracts, retinal pigmentary 
dystrophy, dysphagia, postural and gait instability and myopathy with prominent exercise 
intolerance. The mutation causes a deletion of 18 bps and consequently the loss of six 
aminoacids (Ile-Leu-Ala-Met-Ile-Pro) from the position 300 to 305 in the sixth trans 
membrane helix of the protein (Figure 4.1A and B), but leaving the remaining of the 
cytochrome b sequence in frame [Carossa et al., 2014]. 
To evaluate in detail the biochemical alterations associated with the two MTCYB 
mutations, we took advantage of the cybrid clones generated from the patient’s fibroblasts 
[King and Attardi, 1996]. For more details see paragraph 3.1 of Experimental Procedures. 
Cybrid clones were obtained by the fusion of enucleated patient fibroblasts bearing the 
mutation of interest with 143B.TK- osteosarcoma cells depleted by their own mtDNA 
(Rho0 cells). Cybrids are a useful tool in studying mtDNA mutations, 
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since they allow assaying the donor mitochondrial function in a “standard” nuclear 
background, thus excluding nuclear influences and variables. In general, from the 
cybridization process of each mutation, several syngeneic clones were obtained harboring 
various percentage of mutated mtDNA, so that the mutant cell line can be compared with 
a control cell line bearing the 100% of its own wild-type mtDNA.  
Homoplasmic wild-type clones (100% wild-type mtDNA) and homopasmic 
mutated clones (100% of mutated mtDNA) were selected for the present studies. For the 
p.278Y>C mutation several heteroplasmic clones were obtained from the cybridation 
procedure (58, 78, 96% of mutation load). For the ΔI300-P305 microdeletion, only one 
clone 80% heteroplasmic was obtained. The level of heteroplasmy was evaluated by PCR, 
amplifying MT-CYB gene and then using denaturing high-performance liquid 
chromatography (DHPLC) [Kurelac et al., 2012], as described in Experimental Procedures. 
 
 
 
Figure 4.1 (A) Representation of cytochrome b protein structure. The position of p.278Y>C and ΔI300-P305 
mutations are indicated [modified from Gao et al., 2003]. (B) Cytochrome b protein sequence alignment of 
p.278Y>C and ΔI300-P305 mutations in different organisms. 
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4.1 Viability of cybrids bearing the MTCYB mutations after metabolic 
stress  
The effect of the p.278Y>C and ΔI300-P305 mutations on the mitochondrial 
energetic function was first investigated by measuring the viability of cybrid clones during 
incubation in a glucose-free medium containing galactose and pyruvate [DMEM-galactose]. 
Under these conditions, the rate of glycolysis is markedly reduced, and cells are forced to 
rely solely on OXPHOS for ATP production [Robinson, 1996]. Figure 4.2, panel A, 
illustrates the data obtained in cells bearing the p.278Y>C mutation. The viability of the 
homoplasmic mutated clone was dramatically decreased compared with control cybrids 
after 16–24 hours of incubation in DMEM-galactose. Conversely, all the heteroplasmic 
clones were not significantly different from wild-type cybrids. On the basis of these results, 
our subsequent studies were performed in the homoplasmic 100% mutant clone only. 
In Figure 4.2, panel B, the results of analysis carried out in cybrids with the 
ΔI300-P305 microdeletion are reported. Already after 6 hours of incubation in DMEM-
galactose, less than 20% of the homoplasmic mutant cybrids were still viable. Conversely, 
approximately 70% of the heteroplasmic cybrids were still viable after 24 hours of 
incubation in DMEM-galactose, being significantly different from control cybrids. These 
findings clearly indicate that the ΔI300-P305 deletion is very detrimental when homoplamic 
and that the presence of 80% mutated gene can affect OXPHOS efficiency. From these 
results we decided, in the case of the ΔI300-P305 deletion, to carry out further experiments 
in the homoplasmic and 80% heteroplasmic clones. 
It is apparent in Figure 4.2 that the viability in DMEM-galactose is different in the 
two control cybrids (panel A versus panel B). As described above, the control cybrids were 
obtained through the cybridation of fibroblasts derived from the two patients, each with its 
own mtDNA, characterized by a specific variability mainly due to the polymorphisms 
present in the mtDNA sequence. The mtDNA haplogroup of patient bearing the 
p.278Y>C mutation was X2c, whereas that of patient with the ΔI300-P305 microdeletion 
was T2c1. This difference can explain the different viability shown by the two control cell 
lines. 
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Figure 4.2 Time course of cell viability in DMEM-galactose. (A) p.278Y>C and (B) ΔI300-P305; the 
mutation load of each clone is indicated in the legend. The SRB absorbance value at time zero corresponds to 
100% viable cells. Each data point represents mean ± SEM of at least three experiments (P* ≤ 0.05; P** ≤ 
0.01). 
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4.2 Expression level of respiratory complex subunits 
We then inquired whether the p.278Y>C and ΔI300-P305 mutations alter the steady-
state expression level of respiratory complex subunits. Crude mitochondria were isolated 
from cybrid clones and separated on SDS-PAGE using a 12% acrylamide gel, as described 
in Experimental Procedures. As reported in Figure 4.3, the levels of representative subunits 
of different complexes were similar in control cybrids and in cybrids bearing the p.278Y>C 
mutation, ruling out a reduction of respiratory complexes. Conversely, representative 
subunits of both CI and CIII were significantly reduced in the homoplasmic cybrids with 
ΔI300-P305 deletion and also in the heteroplasmic cybrids the expression of CIII-Core2 
subunit was decreased. It follows that the MTCYB microdeletion markedly affects the 
amount of CIII in the heteroplasmic clone and the content of both CI and CIII in the 
homoplasmic clone. 
          
Figure 4.3 Expression level of representative respiratory complexes subunits in mitochondria isolated from 
the indicated cybrids. Mitochondrial proteins were separated by SDS–PAGE and western blot analysis carried 
out using the antibodies against NDUFA9-CI, SDHA-CII, Core2-CIII and CoxIV-CIV. VDAC and actin 
were used for protein content normalization.  
 
Given that the ΔI300-P305 mutation causes the loss of six amino acids in the 
protein, but leaves the remaining sequence in frame, we questioned whether the mutated 
cytochrome b was translated or not. To address this question, cells were labeled with 35S-
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methionine to identify mitochondrially synthesized proteins. Figure 4.4A shows that the 
homoplasmic mutant clone still expressed cytochrome b though at lower amount (about 
50-60%, Figure 4.4B) compared with control, after normalization for total protein loaded 
(Coomassie staining, on the top of panel). A significant reduction was also apparent in the 
level of other mitochondrially encoded subunits of CI and CIV, whereas ATP6 and ATP8 
subunits of CV were not changed (Figure 4.4A and B). Noticeably, in the heteroplasmic 
clone a general increase of mitochondrial protein level, and also of cytochrome b, was 
observed, in agreement with a possible compensatory effect. These results indicate that 
despite the loss of six amino acids, a certain amount of cytochrome b is still expressed. 
 
 
Figure 4.4 Mitochondrial in vitro translation. (A) The autoradiogram displaying the radiolabeled 
mitochondrial translation products and the respective Coomassie stained gel, as a control for loading, are 
shown, with magnification of the area containing cytochrome b . (B) Rate of the global mitochondrial 
proteins and cytochrome b synthesis. Each data point represents mean ± SD of two experiments (P** ≤ 
0.01). 
 
4.3 Molecular dynamic simulation of ΔI300-P305 mutation 
Given that cytochrome b plays a key role in the first assembly step of the mature 
CIII, we decided to define the predicted structure of the ΔI300-P305 cytochrome b and its 
putative effect on the assembly of the entire CIII. To this purpose, we used a variety of 
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bioinformatics programs, ad described in Experimental Procedures, to remove the deleted 
amminoacids from the PBD file based on the crystal structure of the entire CIII in Bos 
taurus obtained by Iwata and colleagues in 1998 [Iwata et al., 1998], and isolated the α-
helices of the neighboring subunits. 
The entire mutated cytochrome b along with cytochrome c, Rieske protein, 
subunits 6 and 7 were tested in a simulation run in silico for 10ps in vacuum to evaluate the 
reorganization of mutated protein in comparison with wild-type. The microdeletion causes 
the shortening of the sixth trans-membrane α-helix; as a result the neighboring loop, 
including some hydrophilic amminoacids, becomes longer and gives more mobility to the 
structure, being the subunit less stable within the membrane. The four cytochrome b α-
helices that form the bundle coordinating the prosthetic groups heme bH and heme bL (in 
blue-green, Figure 4.5, right panel) seem not to be involved in the general re-arrangement 
of the protein, suggesting that it might be still functional. The most significant change 
regards the adjacent subunits, being their position quite different from the wild-type, likely 
influencing the structure of the entire CIII. This simulation only provides us a general view 
of structure, being run in vacuum, so we cannot rule out a protective effect of the 
membrane, in particular of cardiolipin, the mitochondrial phospholipid hallmark, which has 
been recently reported to be present with a stoichiometry of at least eight molecules per 
CIII [Bazán et al., 2013]. In addition, CIII does not exist in the inner mitochondrial 
membrane only as a dimer, but it is also associated within SCs with CI and CIV; the 
interaction with other respiratory enzymes can stabilize the CIII at least in that forms. 
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Figure 4.5 In silico simulation of the mutated protein re-organization. Left: structure of wild-type subunits 
(Cyt b, Cyt c, Sub6, Sub7 and Rieske protein) within CIII2, the amminoacids deleted in the mutant are 
evidenced in red. Right: simulation of the structure changes in mutated cytochrome b. Blue and green colors 
represent the unchanged residues compared to WT, red residues represents residues that has been rearranged 
after the simulation. 
 
4.4 Analysis of respiratory complexes assembly and activity 
The assembly and activity of the respiratory chain complexes were then investigated. 
Figure 4.6 shows the assembly of respiratory complexes, analyzed by using BN-PAGE of 
mitoplasts treated with 2% docecyl-maltoside (DMM), a detergent which completely 
dispersed the respiratory supercomplexes [Nijtmans et al., 2002].  
The p.278Y>C mutated clones did not show any significant difference compared 
with control cells, when normalized to the amount of CII, except for the absence of the 
CIII2+IV SC. Given the strong interactions between CIII2 and CIV, the CIII2+IV SC was 
detected also in the presence of DDM, as apparent in the wild type clone. It seems 
therefore that the missense mutation did not affect CIII2 assembly, but rather weakened the 
CIII2 and IV interaction. 
In the ΔI300-P305 homoplasmic mutated clone, the level of a representative subunit 
of CI, as well as the CI-In Gel Activity, were almost not detectable, whereas no significant 
difference was observed in the heteroplasmic compared with control clone. Furthermore, 
no band corresponding to CIII2 and the CIII2+IV SC was detected in the homoplasmic 
mutant clone, while in heteroplasmic cells only the band corresponding to CIII2 was 
present. The amount of assembled CIV and CII was normal in the homoplasmic mutant 
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clones and even increased in heteroplasmic cells, in agreement with the results of the in vitro 
translation experiments (Figure 4.4A and B; Figure 4.6). These results suggest that when 
mutant cytochrome b only is present, the assembly of both CIII2 and CI is affected, 
whereas, when both mutant and wild-type proteins are expressed, the formation of the 
CIII2+IV SC only is compromised. 
 
               
Figure 4.6 Analysis of respiratory complexes assembly in crude mitochondria. BN-PAGE of p.278Y>C and 
ΔI300-P305 mitoplasts, in the presence of 2% DDM; for the western-blot analysis, antibodies against 
NDUFA9-CI, SHDA-CII, Core2-CIII and CoxIV-CIV were used. 
 
Figures 4.7A and B report the p.278Y>C and ΔI300-P305 respiratory complexes 
redox activities, measured in crude mitochondria, as described in Experimental Procedures. 
In mitochondria with the p.278Y>C mutation, CIII specific redox activity was almost 
completely lost when compared with control, while the redox activity of CI, CII and CIV 
was not affected (Figure 4.7A). 
As shown in the Figure 4.7B, the ΔI300-P305 heteroplasmic clone displayed a 
significant reduction of CIII and CIV redox activities, while the homoplasmic mutant clone 
exhibited a significant decrease in CI, III, and IV activities, suggesting a more general effect 
of this MTCYB mutation on the respiratory chain activity. Remarkably, a significantly 
increase in CII redox activity was detected in the homoplasmic clones.  
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Figure 4.7 Analysis of the respiratory complexes redox activity in crude mitochondria. Measurement of CI, 
CII, CIII and CIV redox activity in p.278Y>C (A) and in ΔI300-P305 (B). Each data point represents the 
mean ± SD of at least three experiments (P* ≤ 0.05; P** ≤ 0.01).  
 
4.5 Analysis of the respiratory complexes supramolecular organization 
We also examined the supramolecular organization of the respiratory complexes in 
cybrids bearing the two MTCYB mutations. Figures 4.8 and 4.9 show the SCs assembly of 
p.278Y>C and ΔI300-P305 mitoplasts solubilized with digitonin, a mild detergent which 
keeps intact loose interactions among complexes [Schägger and Pfeiffer, 2000], by 
measuring the CI-In Gel Activity after Blue Native-PAGE (BN-PAGE) and performing 
western blotting after two dimensional BN/SDS-PAGE (2D BN/SDS–PAGE).  
In p.278Y>C mitoplasts, the CI-In Gel Activity was slightly increased in the band 
corresponding to the CI+III2+IV SC while the other CI-containing SCs were similar to 
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control (Figure 4.8A). The 2D BN/SDS–PAGE analysis showed a similar behavior, and in 
addition evidenced that the spots corresponding to the CIII2 and the CIII2+IV SC were 
reduced when compared with control cells (Figure 4.8B). These findings suggest that the 
p.278Y>C MTCYB mutation only slightly affect the organization of respiratory complexes 
into SCs. 
 
Figure 4.8 BN-PAGE analysis of SCs in digitonin-treated mitoplasts from cybrids bearing the p.278Y>C 
mutation. (A) CI-In Gel Activity; (B) 2D BN/SDS–PAGE followed by western-blot; antibodies against 
NDUFS3-CI, SDHA-CII, Core2/Rieske-CIII and CoxIV-CIV were used. 
 
In Figure 4.9A, a representative gel of CI-In Gel Activity of mitoplasts obtained 
from cybrids with the ΔI300-P-305 deletion is reported. It is apparent that the band 
corresponding to the CI-CIII2 SC is detected in all clones, indicating that its assembly is 
preserved also in homoplasmic mutant cells, despite the strong reduction of CI and CIII 
levels. Furthermore, it is clear that the other SCs containing various amounts of CI, III2 
and IV were similar in control and heteroplasmic clones, but not present in the 
homoplasmic mutant clone. These results were also confirmed by performing 2D 
BN/SDS–PAGE as shown in the Figure 4.9B. Moreover, the spots corresponding to CIII2 
and CIII2+IV SC were reduced in the heteroplasmic clone and almost abolished in the 
homoplasmic clone, in agreement with the results obtained with the isolated complexes. In 
addition, the mutant clones showed a peculiar high molecular weight supercomplex (called 
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super-supercomplex, SSC), which was enzymatically active, as demonstrated by the CI-In 
Gel Activity (Figure 4.9A), and contained CIII and CI (Figure 4.9B). To better evaluate the 
composition of the SSC, we excided the bands corresponding to SSC from the gels of both 
mutated clones and from the apparently empty gel of the control clone. Then, we run the 
bands on SDS-PAGE and performed western blot for representative subunits of the three 
complexes. Figure 4.10 shows that in all clones the bands were positive to CIII and CIV, 
whereas CI was detected in mutant clones only. The presence of CIII and CIV also in the 
wild-type clone may be due to the presence of SC with different CIII/CIV stoichiometry, 
much more abundant than CI, as reported by others [D’Aurelio et al., 2006; Schägger, 
2002].  
Altogether the results obtained in complexes/SCs analysis allow us to conclude that 
ΔI300-P305 microdeletion causes the almost complete disassembly of CIII and CI as well 
as re-organization of SCs, with formation of very high molecular weight aggregate. 
However, also in the homoplasmic mutant clone, the CI and CIII interaction is still 
preserved.  
 
Figure 4.9 BN-PAGE analysis of SCs in digitonin-treated mitoplasts from cybrids bearing the ΔI300-P305 
deletion. (A) CI-In Gel Activity; (B) 2D BN/SDS–PAGE followed by western-blot with antibodies against 
NDUFS3-CI, SDHA-CII, Core2-CIII and Cox5A-CIV. 
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Figure 4.10 SDS-PAGE followed by western-blot analysis of the bands corresponding to the SSC excised 
from the gels. Antibodies against NDUFS3-CI, SDHA-CII, Core2-CIII and CoxIV-CIV were used. 
 
4.6 Combined redox activities and ATP synthesis  
The combined redox activities (CI+CIII and CII+CIII) were measured in crude 
mitochondria isolated from cybrids bearing the two MTCYB mutations.  
In cells with the p.278Y>C mutation, the CI+CIII combined redox activity of 
homoplasmic mutant clone was markedly reduced compared with control, but less severely 
than CIII alone (Figure 4.7A), whereas the CII+CIII did not show significant difference 
(Figure 4.10A).  
In cybrids harboring the ΔI300-P305 deletion, the CI+III and CII+III integrated 
activities of the heteroplasmic clone were not different from control. In the homoplasmic 
mutant clone the CI+CIII integrated activity was also similar to control, in accord with the 
results of BN-PAGE, while the CII+CIII activity was almost abolished (Figure 4.11B). 
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Figure 4.11 Analysis of combined redox activities (CI+CIII and CII+CIII) measured in crude mitochondria 
and expressed in nmol/min*mg. (A) p.278Y>C; (B) ΔI300-P305. Each data point represents mean ± SD of 
three experiments (P* ≤ 0.05; P** ≤ 0.01). 
 
Further analysis of the OXPHOS efficiency was performed by measuring the rate of 
mitochondrial ATP synthesis in digitonin-permeabilized cells, after normalization for the 
citrate synthase activity, which is an indicator of the mitochondrial mass [Trounce et al., 
1996].  
The ATP synthesis rate of p.278Y>C cybrids was reduced (∼ 35%) in presence of 
the CI substrates malate plus pyruvate, but only slightly affected in presence of the CII 
substrate succinate (Figure 4.12A). These results are in accord with the findings obtained 
Results 
74 
 
by analysis of respiratory SCs (Figure 4.8 A and B), which were not significantly affected by 
the mutation.  
In ΔI300-P305 mutated cybrids, the rates of ATP synthesis driven by CI and CII 
substrates were all severely reduced or abolished in the homoplasmic mutant clone only. In 
heteroplasmic cybrids, the ATP synthesis was similar or only slightly reduced compared 
with controls, indicating that the presence of about 20% wild-type mtDNA is sufficient to 
sustain the mitochondrial function (Figure 4.12B). The residual ATP synthesis value in 
homoplasmic clone is in accord with the presence of the CI+III2 SC and CI+CIII 
integrated activity, indicating that mutated CIII associated with CI within the SCs is able to 
perform some residual activity. 
 
 
Figure 4.12 Mitochondrial ATP synthesis rate driven by CI and CII substrates in (A) p.278Y>C and (B) 
ΔI300-P305. Data are expressed as ATP synthesis/CS activity. Each data point represents mean ± SD of 
three experiments (P* ≤ 0.05; P** ≤ 0.01). 
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4.7 Oxidative damage associated with p.278Y>C mutation 
Recently, it has been demonstrated that the R. capsulatus cytochrome b p.302Y>C 
substitution, which is homologous to human cytochrome b p.278Y>C, induced superoxide 
production by CIII. Remarkably, mass spectrometry analysis showed that this mutation 
caused chemical cross-linking of cytochrome b to the Fe/S subunit by a disulfide bond, 
rendering the bacterial enzyme inactive [Lee et al., 2011]. Enhanced superoxide production 
was also measured in mitochondria isolated from p.278Y>C mutant cybrids, compared to 
wild type cells [Lanciano et al., 2013]. Therefore we decided to determine the amounts of 
reduced glutathione (GSH) and oxidized glutathione (GSSG) in cybrids grown in galactose-
containing media, given that glutathione is involved in the detoxification of a number of 
oxidizing species and changed GSSG/GSH ratio provide strong evidence for occurrence 
of an oxidative stress [Hansen et al., 2006]. Although the GSSG/GSH+GSSG ratio was 
only slightly increased in mutant cybrids grown in DMEM in comparison with wild-type 
cells (Figure 4.12A), a significant increase of this ratio was detected after 6 hours of 
incubation in DMEM-galactose (Figure 4.13A), a time point where most of the mutant 
cells were still viable (see Figure 4.2A). This finding indicates that an imbalance in the 
homeostasis of the major intracellular tripeptide antioxidant, likely as a consequence of the 
superoxide production by mutated CIII, becomes apparent when cells are forced to use 
oxidative metabolism. 
This result prompted us to determine whether the addition of exogenous 
antioxidants might ameliorate the viability of mutated cells incubated in DMEM-galactose. 
As illustrated in Figure 4.13B, addition of the selective superoxide scavenger sodium 4,5-
dihydroxybenzene-1,3-disulfonate (Tiron; 10 mM) [Taiwo, 2008] improved the viability of 
mutated cybrids after 24 hours of incubation in DMEM-galactose (48% increase). 
Furthermore, the presence of 10mM GSH or N-acetylcysteine (NAC) significantly 
increased the viability already after 16 hours of incubation (30 and 76% increase, 
respectively) and also after 24 hours of incubation (54 and 32% increase, respectively). All 
these compounds slightly reduced the viability of control cybrids. Taken together, these 
results indicate that the loss of viability of cybrids carrying the cytochrome b p.278Y>C 
mutation in DMEM-galactose is due, at least in part, to an imbalance of the GSSG/GSH 
ratio, as a consequence of increased superoxide production. 
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Figure 4.13 Analysis of superoxide production in p.278Y>C. (A) The GSSG/GSH+GSSG ratio was 
measured in cells grown in DMEM or incubated in DMEM-galactose for 6 hours, as described in 
Experimental Procedures. Values are expressed as percent increase over respective control (none). Data are 
presented as the means ± SD of three determinations (P* ≤ 0.05). (B) Cybrids were incubated in DMEM-
galactose in the absence or the presence of 10 mm GSH or 10 mm NAC or 10 mm Tiron. The 100% value 
corresponds to viability determined for each cell line after incubation for the indicated times in DMEM-
galactose. Values are presented as the means ± SD of three determinations (P* ≤ 0.05). 
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Then we asked whether the addition of the strong reducing agent dithiothreitol 
(DTT) to the mitochondrial isolation buffer could improve the CI, CIII and CI+III 
activities of p.278Y>C crude mitochondria. In the presence of DTT, the CIII and CI+III 
activities significantly increased (Figure 4.14A), but not in control mitochondria (data not 
shown). These results suggested that the CIII activity is affected by enhanced oxidative 
stress, and that reducing conditions significantly preserving the CIII and CI+CIII activities, 
contribute to improve the viability in galactose medium. 
 
Figure 4.14 (A) CI, CIII and CI+III redox activities were determined in crude mitochondria from Y278C 
mutant cybrids isolated in a buffer without or with 10mM DTT, as described in Experimental Procedures. 
Data are presented as % values ± SD of five determinations (P* ≤ 0.05). (B) CI, CIII and CI+III activities 
were determined in crude mitochondria and in mitoplasts solubilized with digitonin, as detailed in 
Experimental Procedures. Data are expressed as ratio of digitonin-treated mitoplasts to crude mitochondria 
enzymatic activity. Data are presented as mean ± SD of five determinations (P* ≤ 0.05). 
 
Furthermore, we considered the possibility that isolation of mitoplasts by digitonin-
treatment should better protect mitochondrial membranes from the damaging effects of 
oxygen, and therefore we decided to measure the CI, CIII and CI+CIII activities in 
digitonin-extracted mitoplasts. These activities have been compared with those obtained in 
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crude mitochondria, that we believed were likely more exposed to oxygen during the 
isolation procedure involving potter homogenization. Figure 4.14B shows that the CIII 
activity was significantly higher in digitonin-treated mitoplasts compared with crude 
mitochondria, whereas the CI and CI+III activity were similar. No difference was observed 
in a similar experiment carried out in control cybrids (data not shown). These findings 
support the hypothesis that, similarly to bacteria [Lee et al., 2011] also in human mutant 
cells, oxygen plays a detrimental effect on the respiratory CIII. 
 
4.8 Hydrogen peroxide production and CII activation in cell bearing 
the ΔI300-P305 deletion  
It has been recently reported that CI dysfunction associated with marked increase in 
hydrogen peroxide production, causes stimulation of CII redox activity, through a 
mechanism mediated by Fgr tyrosine kinase phosphorylation. Interestingly CII activation 
was shown to be specific for CI-deficient cells, since it was not detected in cells with 
defective CIII or CIV. Accordingly, CII activation was proposed to act as a compensatory 
mechanism for counteracting impaired activity of CI [Acín-Pérez et al., 2014]. 
As already reported in Figure 4.7B, the homoplasmic clone harbouring the ΔI300-
P305 microdeletion exhibited a marked increase of CII redox activity compared to wild-
type cells, without any increase in CII protein content (Figure 4.6). In Figure 4.15 the CII 
redox activity of p.278Y>C and ΔI300-P305 homoplasmic clones is shown. The CII redox 
activity of homoplasmic clone with the ΔI300-P3005 microdeletion was strongly increased 
(more than 2-fold) compared with control, whereas no stimulation was apparent in the 
p.278Y>C homplasmic clone. Thus, we decided to investigate whether the increased CII 
activity of the homoplasmic ΔI300-P305 clone was associated in vivo with an 
overproduction of H2O2. Cybrids bearing the p.278Y>C mutation were used as a negative 
control. 
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Figure 4.15 Measurement of CII redox activity in mitochondria isolated from cybrids bearing the indicated 
mutation. Data are expressed as percentage of activity in mutated clone over respective control clone. Data 
are mean ± SD of three determinations (P** ≤ 0.01).  
 
Figure 4.16A reports the production of H2O2, measured by using 2′,7′-
Dichlorofluorescin diacetate (H2DCFDA) as described in Experimental Procedures. A 
highly significant increase in H2O2 production was apparent in the homoplasmic ΔI300-
P305 clone compared with control and the p.278Y>C mutant clone, suggesting that the 
increased CII activity is associated with an overproduction H2O2 production, in agreement 
with [Acín-Pérez et al., 2014]. 
Analysis of the antioxidant enzymes expression by western blotting revealed that 
only the level of peroxiredoxin3, a mitochondrial enzyme known to reduce hydrogen 
peroxide to water and oxygen, was markedly increased in ΔI300-P305 compared to control 
and p.278Y>C clones. The levels of the other antioxidant enzymes catalase and Mn-SOD 
were not affected (Figure 4.16B). 
 
 
Results 
80 
 
 
Figure 4.16 (A) Hydrogen peroxide production in homoplasmic p.278Y>C and ΔI300-P305 clones, 
measured by H2DCFDA fluorescence, expressed as percentage of fluorescence signal of mutated over wild-
type clone. Data are presented as the means ± SD of three determinations (P** ≤ 0.01). (B) Western-blot 
analysis of antioxidant enzymes level using antibodies against catalase, peroxiredoxin 3 and MnSOD. Actin 
was used for protein normalization.  
 
4.9 Phosphorylation of the SDHA subunit of CII  
Activation of CII activity in CI-defective cells was shown to be associated with 
phosphorylation at the tyrosine 604 residue of the SDHA subunit of CII, triggered by the 
tyrosine kinase Fgr [Acín-Pérez et al., 2014]. To assess whether a similar mechanism is also 
active in CIII defective cells, tyrosine phosphorylation of SDHA subunit was determined 
by western blotting (Figure 4.17A).  
By using a P-Tyr antibody, we were able to detected a band at the same molecular 
weight of SDHA in ΔI300-P305, but not in control or p.278Y>C mitochondria, in 
agreement with stimulation of CII activity and hydrogen peroxide production. Further 
evidence for SDHA subunit tyrosine phosphorylation was obtained from 2D BN/SDS–
PAGE experiments. Indeed, as reported in Figure 4.17B, the CII migration pattern was 
Results 
81 
 
different in wild-type and ΔI300-P305 mutant cells, as apparent from both the SDHA and 
P-tyr positive spots, compatible with an increased protein phosphorylation. 
 
Figure 4.17 Analysis of CII SDHA-subunit phosphorylation. (A) SDS-PAGE followed by immunoblot using 
antibodies against SDHA subunit and P-Tyr in p.278Y>C and ΔI300-P305 mutated mitochondria. (B) 2D 
BN/SDS–PAGE using antibodies against SDHA and P-Tyr in ΔI300-P305 mutant clones.  
 
4.10 Effect of treatment of ΔI300-P305 cybrids with NAC 
N-Acetyl-Cysteine (NAC) is a well-known antioxidant involved in hydrogen peroxide 
detoxification, being a GSH precursor [Atkuri et al., 2007]. Thus, to evaluate whether 
increased CII activity and phosphorylation of SDHA subunit were associated with 
hydrogen peroxide production, we incubated homoplasmic ΔI300-P305 cybrids with 5mM 
NAC for a prolonged time (10 days). The CII activity was significantly reduced after 
treatment with NAC compared with untreated cells (Figure 4.18A). Likewise, the hydrogen 
peroxide production was also reduced (Figure 4.18B). Furthermore, the analysis of SDHA 
subunit showed that the band positive to P-Tyr antibody could not be detected in cybrids 
treated with NAC (Figure 4.19). These findings suggest that also in cell defective in CIII, a 
marked stimulation of CII activity occurs, provided that H2O2 production is enhanced, 
leading to phosphorylation of a tyrosine in SDHA subunit. This activation seems strictly 
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dependent on H2O2 overproduction, given that it is abolished after prolonged treatment 
with NAC.  
Figure 4.18 (A) Measurement of CII redox activity in mitochondria from untreated I300-P305 cybrids and 
after 10 days treatment with 5mM NAC. Activity is expressed as percentage of treated over untreated cells. 
Data are presented as the means ± SD of three determinations (P** ≤ 0.01). (B) Measurement of hydrogen 
peroxide production by using H2DCFDA. Data are expressed as percentage of fluorescence of treated over 
untreated cells. Data are presented as means ± SD of three determinations (P** ≤ 0.01). (C) SDS-PAGE 
followed by immunoblot using antibodies against SDHA-CII and P-Tyr. 
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Figure 4.19 Effect of treatment of I300-P305 cybrids with NAC: Western blot analysis of SDHA subunit 
of CII and P-Tyr. 
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Discussion and Conclusions 
The biochemical analysis described in this study was focused on two mutations 
affecting MTCYB gene: the first is the p.278Y>C missense mutation causing the 
substitution of the highly conserved Tyr278, located close the QO site, and leading to 
formation of a chemical cross-linking between cytochrome b and the Fe/S cluster protein. 
The second one, the ΔI300-P305 microdeletion, is located on the sixth transmembrane 
helix and severely reduces the expression level of the protein. 
Although the two mutations differently affected the cytochrome b, similar 
repercussions on CIII activity were observed. In fact, both mutations severely impaired the 
activity of CIII through different mechanisms: the microdeletion caused CIII disassembly, 
conversely, the missense mutation was associated with oxidative injury of CIII, due to 
increased superoxide production. This was confirmed by the imbalance in the cellular 
GSSG/GSSG+GSH ratio detected when the p.278Y>C mutated cells were forced to use 
the OXPHOS and by the efficacy of treatment with the specific superoxide scavenger 
Tiron or with antioxidant compounds such as GSH and NAC. It is noteworthy that in R. 
capsutatus the homologous cytochrome b mutation (p.302Y>C) caused the formation of a 
chemical cross-link between cytochrome b and the Fe/S subunit, enhancing superoxide 
generation and inactivating the bacterial enzyme [Lee et al., 2011]. Further, the same 
authors reported that CIII activity was lower when p.302Y>C cells were grown and 
membranes were isolated in the presence of oxygen. Conversely, the CIII activity was 
increased under anoxygenic photosynthetic growth conditions, and when R. capsutatus 
membranes were isolated in the absence of oxygen [Lee et al., 2011]. In agreement with 
these results, the CIII activity of the p.278Y>C mutant cells significantly increased when 
measured in mitochondria isolated in the presence of the reducing agent DTT.  
It is well established that mutations affecting CIII and causing its loss, indirectly 
impair the assembly of CI [Acín-Pérez et al., 2004; D’Aurelio et al., 2006; Diaz et al., 2006; 
Diaz et al., 2012a, 2012b; Li et al., 2007]. Our results confirm the hypothesis that CI and 
CIII are strictly dependent, given that in ΔI300-P305 cells the impairment of CI correlated 
with the absence of CIII. On the other hand, the missense MTCYB 
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mutation, which did not perturb the assembly of CIII, failed to affect CI activity and 
assembly.  
The analysis of SCs organization in cells with the two mutations revealed the 
absence of CIII2+IV SC together with the attempt to preserve the respirasome. Indeed, in 
p.278Y>C, we observed a slightly increase of CI+III2+IV SC. Furthermore, we observed 
that the residual CIII activity of mutated cells was higher when measured in digitonin-
solubilized mitoplasts compared with crude mitochondria, suggesting that CIII activity is 
protected when included within the CI+III2+IV SC. Further support to this derives from 
the finding that the combined CI+CIII activity significantly increased when measured 
under reducing conditions. It is therefore likely that during the isolation procedure of crude 
mitochondria by using potter omogenization, cells are more exposed to the damaging 
effect of oxygen than when mitochondria are isolated by digitonin treatment. Under these 
milder conditions, CIII and SCs should be protected from detrimental effects of oxygen. In 
this regard, the importance of SCs association to safeguard the respiratory complexes from 
oxidative damage, not only allowing a better substrate channeling but also maintaining the 
redox centers of the complexes less exposed to oxygen has been recently underlined 
[Maranzana et al., 2013].  
In ΔI300-P305 homoplasmic cells, we observed the maintenance of a small 
amount of enzymatically active CI+CIII2 SC, despite disassembly of CI and CIII and 
severe impairment of redox activities, allowing for a minimum rate of ATP synthesis. 
Moreover, in the heteroplasmic mutant cells, the amount of the CI+III2+IV SC was similar 
to controls. These results strongly confirm the proposal that CI has a very high afﬁnity for 
CIII [Schägger et al., 2004; Schägger and Pfeiffer, 2001] and this association is preferred 
when a partial loss of CIII occurs [Lapuente-Brun et al., 2013], supporting further that the 
organization in SCs is necessary to preserve the structural stability of the complexes but 
also is necessary to maintain their functionality [Maranzana et al., 2013].  
Recently, it has been suggested that the quinone in the inner membrane exists at 
least as two distinct pools: one dedicated to NADH- and the other one to FADH2-
dependent enzymes (CoQNADH pool and CoQFAD pool, respectively). In this scenario, one 
fraction of CIII could bind to CI forming SCs and oxidize the CoQNADH pool, whereas the 
other fraction, mainly present as a dimer, could oxidize the CoQFAD pool. Lapuente-Brun 
and colleagues also observed that the loss of CIII caused the preferentially maintenance of 
CoQNADH oxidation, promoting the association of CI to CIII, despite of the CoQFAD 
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oxidation [Lapuente-Brun et al., 2013]. Our results are in disagreement with this hypothesis, 
since both homoplasmic p.278Y>C and heteroplasmic ΔI300-P305 clones did not 
significantly decrease the ATP synthesis driven by CII and of CII+III combined redox 
activity, suggesting that the SCs association is mostly important to stabilize structurally the 
respiratory complexes, rather than to compartmentalize CoQ into NADH- and the FAD-
dedicated fractions. 
A peculiar finding mostly associated with heteroplasmic ΔI300-P305 is the 
presence of the SSC, a band at very high molecular weight. This unusual high molecular 
weight SC, which was not detected in controls, might derive from the presence of both 
wild-type and mutant cytochrome b in the same cells, a situation similar to that occurring in 
many patient’s tissues. This SSC comprises CI, CIII and CIV, and seems to be 
enzymatically active, as indicated by CI-In Gel Activity. It is known that the SCs can 
organize themself in megacomplexes (or respiratory strings), creating a higher level of 
organization. It has been shown that a supercomplex composed by two copies of CI and 
the CIII2 is present in potato mitochondria (CI2+III2 SC). In turn, this SC can assemble 
with two copies of CIV (CI2+III2+IV2 SC) (Figure 5.1) [Bultema et al., 2009]. It can be 
speculated that the ΔI300-P305 deletion, by deeply altering the structure of CIII, might in 
some way favor its binding with two copies of CI, thus, forming a CI2+III2+IV2 SC. The 
presence of two copies of CI in the SSC might help stabilizing the defective structure of 
CIII, allowing CIV binding. In other words, the lack of CIII2+IV and CI+CIII2+CIV SCs 
might be due to structural changes of mutated CIII which prevent the binding of CIV. Our 
simulation of the structural features of the mutated cytochrome b might support this 
hypothesis. In fact, the “core” structure of the cytochrome b coordinating the bL and bH 
hemes was not significantly changed, whereas the external portion of the protein 
underwent several conformational changes, resulting in increased mobility and possibly 
reduced stability within the membrane. Noticeably, the outer portion is involved in 
interaction with the other subunits of CIII, thus, we speculate that these changes might 
influence the entire structure of the complex and result in a low stability, in turn impairing 
its assembly, function and the capability to bind CIV. However, it has to be considered that 
this bio-informatic analysis was performed considering the protein structure in vacuum. 
Indeed, the respiratory enzymes are embedded within the inner membrane, in a highly 
hydrophobic environment. Therefore, these are only speculations to predict the effect of 
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altered cytochrome b structure, further studies using more sophisticated approaches are 
required to address this issue. 
 
Figure 5.1 Representation of CI2+III2+IV2 SC. CI is indicated in red, CIII in yellow and CIV in green. 
 
 
In conclusion, the analysis of the supramolecular organization of mitochondrial 
respiratory complexes in cells bearing the p.278Y>C and ΔI300-P305 mutations allowed us 
to shed light on the subtle underlying molecular alterations, providing information that 
could be possibly useful for optimization of future treatment of patients. Furthermore, our 
studies favor the hypothesis that SCs are necessary not only for channeling electron 
transport between complexes but also, and likely more importantly, to preserve the 
structure and stability of respiratory complexes, attenuating the mitochondrial dysfunction 
due to mutations affecting the enzymes. In fact, our results reinforce the notion that CI 
and CIII have a strict structural dependence, which is a crucial element for their proper 
functioning (Figure 5.2). 
The other original finding emerging from our biochemical studies on cells bearing 
the ΔI300-P305 deletion is the strong increase of CII redox activity associated with the 
complete inhibition of CIII. This finding is in disagreement with previous reports [Acín-
Pérez et al., 2014] where over-stimulation of CII activity was not detected in CIII defective 
cells, but only in those bearing mutated ND6 subunit of CI. Accordingly, increased CII 
activity was proposed to be a compensatory mechanism to bypass the CI defect. In our 
case, hyper-activation of CII activity in the homoplasmic ΔI300-P305 clone bearing a faulty 
CIII, makes it difficult to envisage the occurrence of any compensatory mechanism.  
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Figure 5.2 Schematic representation of SCs and complexes organization in (A) p.278Y>C and (B) ΔI300-
P305. CI is indicated in red, CIII in green and CIV in yellow. 
 
Our efforts have been focused on investigation of the mechanism underlying the 
activation of CII redox activity. It is well known that CII is a substrate of the Fgr tyrosine 
kinase, resulting in phosphorylation of several tyrosine residues [Salvi et al., 2005]. 
Furthermore, the association of the CII activation with phosphorylation of the SDHA-CII 
subunit on the Tyr604 has been recently demonstrated [Acín-Pérez et al., 2014]. In 
agreement, we also evidenced that stimulation of CII activity was associated with tyrosine 
phosphorylation of the SDHA subunit of CII. Furthermore, cells bearing the ΔI300-P305 
deletion exhibited a marked increase of H2O2 production associated with the hyper-
activation of CII.  
The source of H2O2 in the homoplamic ΔI300-P305 cells remains to be identify. 
The small amount of CI+III still present might be involved, given that CI and CIII are 
considered the major ROS producers within the inner membrane. However, also CII can 
generate free radicals [Quinlan et al., 2012]. Thus, it is possible that the high H2O2 
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production can originate from CII consequently to its hyper-activation. Moreover, we have 
shown that the over-production of H2O2 is associated with a markedly increased level of 
Prx3, an antioxidant enzyme specifically involved in H2O2 detoxification. It is well known 
that ROS can act as signaling molecules activating transcriptional factors involved in the 
expression of genes responsible for translation of antioxidant proteins, such as Keap1. This 
protein has been reported to be a sensor of oxidative stress, since it contains many cysteine 
residues through which Keap1 should sense the oxidative stress [Holland and Fishbein, 
2010]. Under basal conditions, Keap1 sequesters Nrf2 in the cytosol facilitating its 
ubiquitination and proteasomal degradation. When a redox stress occurs, the reactive 
cysteine residue oxidation causes conformational changes in Keap1, resulting in the release 
of Nrf2 which is no longer ubiquitinated and degraded, allowing its translocation to 
nucleus. Here, Nrf2 binds to the antioxidant response element (ARE) activating the 
expression of genes involved in the oxidative stress detoxification [Bryan et al., 2013]. Our 
preliminary experiments of western blotting indicate that in ΔI300-P305 cells Nrf2 was 
stabilized and found associated with the nuclear fractions (data not shown). It is therefore 
likely that over-production of H2O2 could trigger the activation of antioxidant enzymes 
such as Prx3 through Nrf2-Keap1 pathway. In Figure 5.3, a model of the pathways 
possibly activated in ΔI300-P305 cells is summarized. 
 
Figure 5.3 Scheme of the pathways possibly activated in homoplasmic ΔI300-P305 cells. 
 
Finally, experimental conditions leading to reduction of oxidative stress, such as 
prolonged treatment of ΔI300-P305 mutant cells with NAC, significantly decreased H2O2 
production. The diminished H2O2 production and, consequently, decreased CII activity 
were associated with de-phosphorylation of SDHA-CII subunit, indicating that the 
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signaling mechanism involves a ROS-type molecule. Further experiments are required to 
confirm the occurrence of this pathway. Noticeably, cells with the p.278Y>C MTCYB 
mutation did not exhibit any H2O2 overproduction, nor increased Prx3 expression level or 
phosphorylation of SDHA-CII subunit, in accord with the normal CII redox activity. This 
also suggests that defective CIII in the absence of H2O2 overproduction is not sufficient to 
induce CII activation.  
In conclusion, our data suggest that hyper activation of CII, associated with 
MTCYB microdeletion and dependent on CIII alteration and hydrogen peroxide 
overproduction, is a more general phenomenon than predicted. The consequences of CII 
stimulation is still poorly understood, and this is particularly relevant in the case of 
association with defective CIII, where a compensatory role has to be ruled out. It is 
possible that it is associated with production of specific signaling metabolites, that might 
trigger activation of particular cellular responses. Indeed significant changes in the 
metabolic intermediates of the tricarboxylic acid cycle have been recently described in cells 
exposed to OXPHOS complexes inhibitors or containing mitochondrial dysfunctions 
[Mullen et al., 2014]. Therefore cells bearing the homoplasmic ΔI300-P305 deletion 
represent a precious model to better understand CII activation and the related cellular 
events, and to shed light on metabolic adaptation/remodeling due to respiratory chain 
dysfunctions. 
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